Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20030176875 A1
Publication typeApplication
Application numberUS 10/386,897
Publication date18 Sep 2003
Filing date11 Mar 2003
Priority date7 Mar 2002
Also published asUS7070556, US7988615, US20030171644, US20060063968, US20110282133
Publication number10386897, 386897, US 2003/0176875 A1, US 2003/176875 A1, US 20030176875 A1, US 20030176875A1, US 2003176875 A1, US 2003176875A1, US-A1-20030176875, US-A1-2003176875, US2003/0176875A1, US2003/176875A1, US20030176875 A1, US20030176875A1, US2003176875 A1, US2003176875A1
InventorsKimberly Anderson, Brian Watschke, Georges Mellier, Johann Neisz
Original AssigneeAnderson Kimberly A., Watschke Brian P., Georges Mellier, Neisz Johann J.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Transobturator surgical articles and methods
US 20030176875 A1
Abstract
Surgical articles, implants and components suitable for a transobturator surgical procedure are described.
Images(42)
Previous page
Next page
Claims(40)
What is claimed is:
1. A surgical instrument for implanting an implantable material to treat incontinence, the instrument comprising:
a handle portion,
a second portion having substantial structure in three dimensions and a distal region, the second portion including a needle portion having a portion that is sized and shaped to extend between an incision substantially adjacent the patient's obturator foramen and a vaginal incision; and
the needle portion having structure in the distal region for associating the instrument with an implantable material for treating the incontinence.
2. A surgical instrument according to claim 1 wherein the needle portion includes a portion that is substantially helically shaped.
3. A surgical instrument according to claim 2 wherein the substantially helically shaped portion comprises a variable helix shape.
4. A surgical instrument according to claim 1 wherein the handle portion is elongate along a handle axis, the second portion includes a substantially straight spacer portion along the handle axis, and a variable spiral portion extending from the spacer portion.
5. A surgical instrument according to claim 4 wherein the variable spiral portion has a tissue clearance depth of greater than about 0.5 inches and less than about 2.5 inches.
6. A surgical instrument according to claim 4 wherein the variable spiral portion has a maximum width of greater than about 1.25 inches and less than about 3 inches.
7. A surgical instrument according to claim 1 wherein structure for associating the instrument with an implantable material comprises an eyelet.
8. A surgical instrument according to claim 1 wherein the handle portion is elongate defining a mid plane, and the distal end includes a distal tip situated substantially near an extension of the mid plane that is spaced from the handle portion.
9. A surgical instrument according to claim 1 wherein the needle portion includes a substantially circular cross sectional shape with a diameter less than about 4 mm.
10. A surgical instrument for treating incontinence, the instrument comprising:
first and second ends, the instrument having a needle portion on the first end;
the second end having a handle, at least the needle portion having a securement surface for snap fitting the instrument to another surgical component used to treat the incontinence, the snap fit providing a substantially permanent attachment between the instrument and the other surgical component.
11. A surgical instrument for treating incontinence according to claim 10 wherein the other surgical component comprises a dilator of a sling assembly for treating incontinence.
12. A surgical instrument for treating incontinence according to claim 11 wherein the instrument and the dilator have complementary engagement surfaces for resisting separation of the instrument from the dilator once they are snap fitted together.
13. A surgical instrument for implanting an implantable material to treat incontinence, the instrument comprising:
a handle portion,
a second portion having an extension portion projecting from the handle portion and a variable spiral portion with a distal region, the variable spiral portion being sized and shaped to extend between an incision substantially adjacent the patient's obturator foramen and a vaginal incision; and
the second portion having structure near the distal region capable of associating the instrument with an implantable material.
14. A surgical instrument according to claim 13 wherein the variable spiral portion has a tissue clearance depth of greater than about 0.5 inches and less than about 2.5 inches.
15. A surgical instrument according to claim 13 wherein the variable spiral portion has a maximum width of greater than about 1.25 inches and less than about 3 inches.
16. A surgical assembly for treating incontinence comprising:
a surgical instrument having a handle portion,
a needle portion having substantial structure in three dimensions and a distal region, the needle portion having a portion that is sized and shaped to extend between an incision substantially adjacent a patient's obturator foramen and a vaginal incision;
an implantable material and a sheath situated about the implantable synthetic material; and
the needle portion having structure in the distal region that is sized and shaped to associate the instrument with the implantable material.
17. A surgical assembly according to claim 16 further including a dilator wherein the dilator has an overall length of less than about 0.7 inches.
18. A surgical assembly according to claim 16 wherein the structure of the needle portion in the distal region for associating the instrument with the implantable synthetic material comprises an eyelet.
19. A surgical assembly according to claim 16 further including a dilator with engagement surfaces for connecting the dilator to the instrument, the dilator operatively associated with the sheath and implantable material;
wherein the structure of the needle portion near the distal region comprises surfaces complementary with the engagement surfaces of the dilator for resisting separation of the instrument from the dilator once they are engaged.
20. A surgical assembly according to claim 16 wherein the needle portion is sized and shaped for a predetermined side of a patient, and the handle portion includes indicia indicating the predetermined side of the patient.
21. A surgical assembly for inserting a implantable material to treat incontinence comprising:
a first surgical instrument for use on a right side of a patient, the first surgical instrument comprising a handle portion and a needle portion having substantial structure in three dimensions and a distal region, the needle portion having a portion that is sized and shaped to extend between an incision substantially adjacent the obturator foramen on the patient's right side and a vaginal incision; and
a second surgical instrument for use on a left side of a patient, the second surgical instrument comprising a handle portion and a needle portion having substantial structure in three dimensions and a distal region, the needle portion having a portion that is sized and shaped to extend between an incision substantially adjacent the obturator foramen on the patient's left side and a vaginal incision.
22. A surgical assembly according to claim 21 wherein the handle portion of the first surgical instrument includes indicia indicating the first surgical instrument is for use on the right side of the patient, and
the handle portion of the second surgical instrument includes indicia indicating the second surgical instrument is for use on the left side of the patient.
23. Am assembly according to claim 21 further including an implantable material formed from knitted polypropylene, and a sheath situated about the implantable material.
24. A surgical assembly according to claim 21 wherein the first and second surgical instruments include an eyelet for receiving a suture to tie the surgical instrument to the implantable material.
25. A surgical assembly according to claim 21 further including an implantable material that includes polypropylene.
27. A universal surgical instrument for treating incontinence comprising:
a needle sized and shaped to either a) initially extend through an incision substantially adjacent a patient's obturator foramen and then through a vaginal incision, or b) initially extend through a vaginal incision and subsequently through an incision substantially adjacent a patient's obturator foramen.
28. A surgical instrument according to claim 27 wherein the needle comprises a pair of ends having surfaces capable of affording association with either an implantable sling material or a removable handle.
29. A surgical assembly according to claim 27 wherein the needle is sized and shaped for use on either the patient's right side or left side.
30. A method of treating incontinence comprising the steps of:
creating a vaginal incision,
creating an incision substantially adjacent the patient's obturator foramen,
providing an elongate surgical instrument comprising first and second regions, with at least one of the regions having a securement surface,
providing a sling assembly having an implantable sling for treating the incontinence, the sling assembly having a surface complementary to the securement surface,
passing the end region having the securement surface between the incisions,
then associating the instrument at the securement surface with the sling assembly to provide a substantially permanent attachment between the instrument and the assembly,
then passing the implantable material through tissue from the vaginal incision toward the incision substantially adjacent the patient's obturator foramen.
31. A method of treating incontinence comprising the steps of:
creating a vaginal incision,
creating an incision substantially adjacent the patient's obturator foramen,
providing an elongate surgical instrument comprising first and second regions, the instrument having substantial structure in three dimensions,
providing an implant for treating the incontinence,
passing a portion of one of the regions between the incisions,
then associating the implant with the instrument, and
passing the implant through tissue and through the patient's obturator foramen with the instrument.
32. A method according to claim 31 wherein the step of providing an elongate surgical instrument includes the step of providing an instrument with a portion that is substantially helically shaped, and the step of passing the implant through tissue includes the step of passing the implant along a substantially three dimensional path.
33. A method according to claim 31 wherein the step of providing an elongate surgical instrument includes the step of providing an instrument with an elongate handle portion having an axis, and
the step of passing a portion of one of the regions between the incisions includes the step of rolling the instrument about the axis of the handle portion.
34. A method of treating incontinence comprising the steps of:
creating a vaginal incision,
creating an incision substantially adjacent the patient's obturator foramen,
providing an elongate surgical instrument comprising a handle portion, a needle portion having an extension portion projecting from the handle portion and a variable spiral portion with a distal region,
providing an implant for treating the incontinence,
passing at least a portion of the variable spiral portion between the incisions by initially passing the distal end through the incision substantially adjacent the patient's obturator foramen and then through the vaginal incision,
then associating the implant with a portion of the instrument that has emerged from the vaginal incision, and
then moving the distal region of the instrument with the implant associated therewith from the vaginal incision toward the patient's obturator foramen to pass the implant through tissue.
35. A method according to claim 34 wherein the step of associating the implant with a portion of the instrument that has emerged from the vaginal incision includes the step of using a suture to tie the implant to an eyelet in the distal region of the needle.
36. A method of treating incontinence comprising the steps of:
creating a vaginal incision,
creating an incision substantially adjacent the patient's obturator foramen,
providing an elongate surgical instrument having first and second regions,
providing an assembly having an implant for treating incontinence,
initially passing the first region initially through the vaginal incision toward the incision substantially adjacent the patient's obturator foramen in a path through the patient's obturator foramen until the first region emerges from the incision substantially adjacent the patient's obturator foramen, leaving the second region projecting from the vaginal incision,
then associating the first region with the assembly, and
then moving the first region out of the patient's body to pass the implant through tissue from the vaginal incision toward the incision substantially adjacent the patient's obturator foramen to place the implant in a therapeutically effective position.
37. A surgical instrument for treating incontinence, the instrument comprising:
a handle portion,
a second portion having an extension portion projecting from the handle portion and a variable spiral portion with a distal region, the variable spiral portion being sized and shaped to extend between an incision substantially adjacent the patient's obturator foramen through the obturator foramen and a vaginal incision; and
the needle portion having structure near the distal region associating the instrument with an implantable material for treating the incontinence.
38. A surgical instrument for treating incontinence, the instrument comprising:
a handle portion; and
a second portion having a medial structure and a helical structure, the medial structure being associated with the handle portion and the helical structure having a distal region, the distal region having structure associating the instrument with an implantable material for treating the incontinence, the helical structure having a longitudinal axis, the handle portion lying substantially along the longitudinal axis.
39. A surgical tool for treating incontinence, the tool comprising:
a handle portion,
a second portion having a medial structure and a needle structure, the medial structure being associated with the handle portion and the needle structure having a distal region, the distal region having structure associating the instrument with an implantable material for treating the incontinence; and
a dilator for association with the implantable material for treating the incontinence and the needle structure, the dilator with having a diameter no greater than the needle.
40. A surgical instrument comprising:
a handle portion,
a second portion having a medial structure and a helical structure, the medial structure being associated with the handle portion and the helical structure having a distal tip, the helical structure having a visual indicator, the visual indicator being indicative of a distance from the visual indicator to the distal tip.
41. A surgical instrument comprising:
a handle portion,
a second portion having a medial structure and a helical structure, the medial structure being associated with the handle portion and the helical structure having a distal tip, the handle having a visual indicator, the visual indicator being indicative of a location of the distal tip.
Description
    CROSS REFERENCE TO RELATED APPLICATIONS
  • [0001]
    The present application claims priority to U.S. Utility application Ser. No. 10/306,179, filed Nov. 27, 2002; and U.S. Provisional Application Serial No. 60/362,806, filed Mar. 7, 2002; and U.S. Provisional Application Serial No. 60/380,797, filed May 14,2002; and U.S. Provisional Application Serial No. 60/402,007, filed Aug. 8, 2002; and U.S. Provisional Application Serial No. 60/414,865 filed Sep. 30, 2002. The entire contents of all of the provisional patent applications are herein incorporated by reference.
  • BACKGROUND
  • [0002]
    Urinary incontinence is a significant health concern worldwide. In the urology field, needles, suture passers and ligature carriers are utilized in a variety of procedures, many of which are designed to treat incontinence. Examples of such surgical instruments included Stamey needles, Raz needles, and Pereyra needles. See Stamey, Endoscopic Suspension of the Vesical Neck for Urinary Incontinence in Females, Ann. Surgery, pp. 465-471, October 1980; and Pereyra, A Simplified Surgical Procedure for the Correction of Stress Incontinence in Women, West. J. Surg., Obstetrics & Gynecology, pp. 243-246, July-August 1959.
  • [0003]
    A pubovaginal sling procedure is a surgical method involving the placement of a sling to stabilize or support the bladder neck or urethra. There are a variety of different sling procedures. Descriptions of different sling procedures are disclosed in U.S. Pat. Nos. 5,112,344; 5,611,515; 5,842,478; 5,860,425; 5,899,909; 6,039,686; 6,042,534 and 6,110,101.
  • [0004]
    Some pubovaginal sling procedures extend a sling from the rectus fascia in the abdominal region, to a position below the urethra, and back again to the rectus fascia. Although serious complications associated with sling procedures are infrequent, they do occur. Complications include urethral obstruction, prolonged urinary retention, bladder perforations, damage to surrounding tissue, and sling erosion.
  • [0005]
    The Tension-free Vaginal Tape (TVT) procedure (available from Ethicon. of N.J.) utilizes a Prolene™ Tm nonabsorbable, polypropylene mesh. Problems with the TVT procedure are documented in the literature and patents. Problems associated with the TVT procedures and the like are acknowledged and described in PCT publication nos. PCT WO 00/74613 and PCT WO 00/74594, U.S. Pat. Nos. 6,273,852; 6,406,423; and 6,478,727, and published U.S. patent application Ser. Nos. 2002-0091373-A1, 2002-0107430-A1, 2002-0099258-A1 and U.S. Pat. No. 2002-0099259-A1. A cadaver study indicated that the TVT needle is placed in close proximity to sensitive tissue such as superficial epigastric vessels, inferior epigastric vessels, the external iliac vessel and the obturator. See, Walters, Mark D., Percutaneous Suburethral Slings: State of the Art, presented at the conference of the American Urogynecologic Society, Chicago (October 2001) and PCT International Publication No. WO 02/26108.
  • [0006]
    Additional sling procedures are disclosed in Published U.S. patent application Ser. No. US 2001/0018549A1, and PCT Publication Nos. WO 02/39890 and WO 02/069781.
  • [0007]
    A significant percentage of pubovaginal sling procedures are conducted after previous pelvic surgery. A pubovaginal sling procedure can be particularly challenging if the patient has scarring as a result of previous pelvic surgeries or other anatomical problems. The additional complications presented by significant scarring present surgeons with a greater surgical challenge and may lead some surgeons to forego an otherwise beneficial sling procedure. Unfortunately, this reduces a patient's options for treating incontinence.
  • [0008]
    Published U.S. patent application Ser. No. 2002/0099260 discloses an implantable device or tape for use in correcting urinary incontinence. The tape includes sprayed polypropylene fibers that result in a strong implantable device. The tape also has a silicone-coated portion and tapered free ends. The procedure utilizes an Emmet needle that includes an eyelet. To create the eyelet, the distal portion of the Emmet needle is enlarged. A surgical procedure using an Emmet needle is believed to be described in the French publication D. Dargent, S. Bretones, P. George, and G. Mellier, Pose d'un ruban sous uretral oblique par voie obturatrice dans le traitement de l'incontinence urinaire feminine, Gynecol. Obstet. Fertil. 2002; 30: 576-582.
  • [0009]
    In the procedure described in U.S. patent application Ser. No. 2002/0099260, an incision is made in the perineal skin facing the obturator and in the groin. The Emmet needle is first inserted through the cutaneous incision. The Emmet needle is first introduced perpendicular to the perineum for about 15 mm (passing through the internal obturator muscle as far as just outside the ischiopubic branch). The Emmet needle is then allowed to describe its curvature. The free end of the tape is then slipped into the eyelet of the needle. The needle/tape connection is thus reversible as one merely needs to unthread the tape from the eyelet to separate the tape from the needle. Separation of the tape and needle while both are within the body is undesirable as it would require the needle to be repassed through the body.
  • [0010]
    The needle with the tape extending through the eyelet is then pulled back though the skin incision. The eyelet and threaded tape present a sudden discontinuity encountered by the tissue that can make tape and needle passage inconvenient and unnecessarily irritative or traumatic to tissue. Additionally, the final placement of the sling may not be optimum in this procedure.
  • SUMMARY OF THE INVENTION
  • [0011]
    In one aspect, the present invention comprises a novel surgical instrument for treating incontinence. The instrument comprises a handle portion, and a needle portion with a distal region. Unlike the Emmet needle of the prior art, the novel instrument has substantial structure in three dimensions. The needle portion is sized and shaped to extend between an incision substantially adjacent the patient's obturator foramen and a vaginal incision. The needle portion also has structure near the distal region for associating the instrument with an implantable material for treating the incontinence. Preferably, the needle portion includes a portion that is substantially helically shaped, more preferably, it is a variable helix shape. The structure for associating the instrument with an implantable material can comprise an eyelet or a dilator or other structure.
  • [0012]
    The handle portion is preferably elongate along a handle axis, the needle portion includes a substantially straight spacer portion along the handle axis, and a variable spiral portion extending from the spacer portion. The variable spiral portion preferably has a tissue clearance depth of greater than about 1.5 inches and less than about 2.5 inches, and a maximum width of greater than about 1.25 inches and less than about 3 inches.
  • [0013]
    In one embodiment, the handle portion is elongate defining a mid plane, and the distal end of the novel needle includes a distal tip situated substantially near an extension of the mid plane that is spaced from the handle portion.
  • [0014]
    In another aspect, the present invention comprises a surgical instrument comprising first and second ends, the instrument having a portion that is sized and shaped to extend between a vaginal incision and an incision substantially adjacent the patient's obturator foramen. One of the ends has a handle, at least the other end having securement surfaces for snap fitting the instrument to another surgical component used to treat incontinence. The snap fit preferably provides a substantially permanent attachment between the instrument and the other surgical component. Preferably, the other surgical component comprises a dilator of a sling assembly. The instrument and the dilator preferably have complementary engagement surfaces for resisting separation of the instrument from the dilator once they are snap fitted together.
  • [0015]
    In another aspect, the novel instrument comprises a handle portion, a needle portion having an extension portion (e.g. a substantially straight portion) projecting from the handle portion and a variable spiral portion with a distal region. The variable spiral portion is sized and shaped to extend between an incision substantially adjacent the patient's obturator foramen and a vaginal incision. The needle portion has structure in the distal region for associating the instrument with an implantable material for treating incontinence.
  • [0016]
    In yet another aspect, the present invention comprises a surgical assembly for treating incontinence. The assembly includes a surgical instrument having a handle portion, a needle portion having substantial structure in three dimensions and a distal region. The needle portion has a portion that is sized and shaped to extend between an incision substantially adjacent a patient's obturator foramen and a vaginal incision. The assembly may also include an implantable synthetic material and a sheath situated about the implantable synthetic material. In this aspect, the needle portion has structure in the distal region for associating the instrument with the implantable synthetic material. The assembly may further including a dilator. Alternatively, needle may comprise an eyelet.
  • [0017]
    When the assembly includes a dilator, the dilator preferably has engagement surfaces for connecting the dilator to the instrument. The dilator is preferably operatively associated with the sheath and implantable material. The structure of the needle portion in the distal region comprises surfaces complementary with the engagement surfaces of the dilator for resisting separation of the instrument from the dilator once they are engaged. Preferably, the needle portion is sized and shaped for a predetermined side of a patient, and the handle portion includes indicia indicating the predetermined side of the patient.
  • [0018]
    In another aspect, the present invention comprises a surgical assembly comprising a first surgical instrument for use on a right side of a patient. The first surgical instrument comprises a handle portion and a needle portion having substantial structure in three dimensions and a distal region. The needle portion has a portion that is sized and shaped to extend between an incision substantially adjacent the obturator foramen on the patient's right side and a vaginal incision. The assembly also has a second surgical instrument for use on a left side of a patient. The second surgical instrument comprises a handle portion and a needle portion having substantial structure in three dimensions and a distal region. The needle portion of the second instrument has a portion that is sized and shaped to extend between an incision substantially adjacent the obturator foramen on the patient's left side and a vaginal incision.
  • [0019]
    Preferably, the handle portion of the first surgical instrument includes indicia indicating the first surgical instrument is for use on the right side of the patient, and the handle portion of the second surgical instrument includes indicia indicating the second surgical instrument is for use on the left side of the patient. The assembly may also include an implantable knitted polypropylene material, and a sheath situated about the implantable synthetic material. The first and second surgical instruments may include an eyelet for receiving a suture to tie the surgical instrument to the implantable material. Alternatively, the assembly can have first and second dilators for associating the first and second surgical instruments with the implantable material.
  • [0020]
    In another aspect the present invention comprises a surgical instrument for treating incontinence comprising a needle sized and shaped to either a) initially extend through an incision substantially adjacent a patient's obturator foramen and then through a vaginal incision, or b) initially extend through a vaginal incision and subsequently through an incision substantially adjacent a patient's obturator foramen. Notably, such a surgical instrument need not have substantial structure in three dimensions. Preferably, the needle comprises a pair of ends having surfaces for affording association with either an implantable sling material or a removable handle. In one embodiment, the needle is sized and shaped for use on either the patient's right side or left side.
  • [0021]
    In another aspect, the present invention comprises methods for treating incontinence. Some methods may utilize substantially three dimensional needles, others need not require three dimension needles and other methods may utilize either three dimensional needles or substantially flat needles or both. One method comprises the steps of creating a vaginal incision, creating an incision substantially adjacent the patient's obturator foramen, providing an elongate surgical instrument comprising first and second regions, with at least one of the regions having securement surfaces, providing a sling assembly having an implantable sling for treating the incontinence, the sling assembly having surfaces complementary to the securement surfaces, passing the instrument between the incisions, then snap fitting the instrument to the sling assembly to provide a substantially permanent attachment between the instrument and the assembly, then passing the implantable material through tissue from the vaginal incision toward the incision substantially adjacent the patient's obturator foramen.
  • [0022]
    In another aspect a method comprises the steps of creating a vaginal incision, creating an incision substantially adjacent the patient's obturator foramen, providing an elongate surgical instrument comprising first and second regions, the instrument having substantial structure in three dimensions, providing an implant for treating the incontinence, passing the first region between the incisions, then associating the implant with the instrument, and passing the implant through tissue and through the patient's obturator foramen with the instrument. Preferably, the step of providing an elongate surgical instrument includes the step of providing an instrument with a portion that is substantially helically shaped, and the step of passing the implant through tissue includes the step of passing the implant along a substantially three dimensional or helical path. The step of providing an elongate surgical instrument preferably includes the step of providing an instrument with an elongate handle portion having an axis, and the step of passing the instrument between the incisions preferably includes the step of rolling the instrument about the axis of the handle portion.
  • [0023]
    In another aspect, the method comprises the steps of creating a vaginal incision, creating an incision substantially adjacent the patient's obturator foramen, providing an elongate surgical instrument comprising a handle portion, a needle portion having an extension portion projecting from the handle portion and a variable spiral portion with a distal end, providing an implant for treating the incontinence, passing at least a portion of the variable spiral portion between the incisions by initially passing the distal end through the incision substantially adjacent the patient's obturator foramen and then through the vaginal incision, then associating the implant with a portion of the instrument that has emerged from the vaginal incision, and then moving the distal region of the instrument with the implant associated therewith from the vaginal incision toward the patient's obturator foramen to pass the implant through tissue. Optionally, the step of associating the implant with a portion of the instrument that has emerged from the vaginal incision includes the step of using a suture to tie the implant to an eyelet in the distal region of the needle.
  • [0024]
    In yet another aspect, the method comprises the steps of creating a vaginal incision, creating an incision substantially adjacent the patient's obturator foramen, providing an elongate surgical instrument comprising first and second regions, providing an assembly having an implant for treating incontinence, initially passing the first region of the instrument initially through the vaginal incision toward the incision substantially adjacent the patient's obturator foramen in a path through the patient's obturator foramen until the first region of the instrument emerges from the incision substantially adjacent the patient's obturator foramen, leaving the second region of the needle projecting from the vaginal incision, then associating the second region of the. instrument that projects from the vaginal incision with the assembly, and then moving the instrument out of the patient's body to pass the implant through tissue from the vaginal incision toward the incision substantially adjacent the patient's obturator foramen to place the implant in a therapeutically effective position.
  • [0025]
    In another aspect, the present invention comprises the ornamental design for a surgical instrument, as shown in FIGS. 39 through 45. and described in the Brief Description of the Drawings. Also, the present invention comprises the ornamental design for a surgical instrument, as shown in FIGS. 46 through 52 and described in the Brief Description of the Drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0026]
    Other features and advantages of the present invention will be seen as the following description of particular embodiments progresses in conjunction with the drawings, in which:
  • [0027]
    [0027]FIG. 1 is a side view of a surgical needle according to one aspect of the present invention;
  • [0028]
    [0028]FIG. 2 is a perspective view of a needle, sling and additional optional elements for use in a kit according to an aspect of the present invention;
  • [0029]
    [0029]FIG. 3 is a top view of a kit according to one embodiment of the present invention;
  • [0030]
    [0030]FIGS. 4 through 10 are schematic views sequentially showing a surgical procedure in accordance with one aspect of the present invention, wherein:
  • [0031]
    [0031]FIG. 4 shows a needle just passing an incision on the right side of a patient's body with the tip of the needle shown in dotted lines;
  • [0032]
    [0032]FIG. 4A is a schematic view of an alternate approach, presented as an alternative to the step shown in FIG. 4, showing an inside-out approach using the needle of FIG. 1, which may be preferred by some surgeon's whose dominant hand is the right hand, the handle shown being a detachable handle that is movable from one region of the needle to the other, with solid lines being used to show the initial position of the handle and dashed lines and an arrow used to show a second position of the handle;
  • [0033]
    [0033]FIG. 5 illustrates a needle just passing an incision on the left side of a patient's body with the tip of the needle and part of the surgeon's finger shown in dotted lines;
  • [0034]
    [0034]FIG. 6 illustrates one side of a sling assembly and the needle of FIG. 5 as it emerges from the patient's vagina;
  • [0035]
    [0035]FIG. 7 shows the sling system of FIG. 6 after it is attached to the needle of FIG. 6;
  • [0036]
    [0036]FIG. 8 is a perspective view of a sling assembly being pulled through the body by a needle in accordance with the present invention,
  • [0037]
    [0037]FIG. 9 is a schematic view of the approximate relative positions of the pubic bone and the sling after the sling is inserted according to one aspect of the present invention;
  • [0038]
    [0038]FIG. 10 is an enlarged schematic view showing portions of FIG. 9;
  • [0039]
    [0039]FIG. 11 is a schematic view of another embodiment of the present invention;
  • [0040]
    [0040]FIG. 12 is a top view of another embodiment of sling for use in accordance with the present invention;
  • [0041]
    [0041]FIG. 13A is a front view of an optional handle suitable for use with the present invention;
  • [0042]
    [0042]FIG. 13B is a side view of the handle of FIG. 13A;
  • [0043]
    [0043]FIG. 14 is a perspective view of the handle of FIGS. 13A and 13B;
  • [0044]
    [0044]FIG. 15 is a perspective view of a surgical instrument particularly suitable for use on a right side of a patient's body, according to one aspect of the present invention;
  • [0045]
    [0045]FIG. 16 is an end view of the needle of FIG. 15;
  • [0046]
    [0046]FIG. 17 is a front view of the needle of FIG. 15;
  • [0047]
    [0047]FIG. 18 is a bottom view of the needle of FIG. 15;
  • [0048]
    [0048]FIG. 15A is a perspective view of a surgical instrument particularly suitable for use on a right side of a patient's body, which needle is similar, but not identical to the needle of FIG. 15;
  • [0049]
    [0049]FIG. 16A is an end view of the needle of FIG. 15A;
  • [0050]
    [0050]FIG. 17A is a front view of the needle of FIG. 15A;
  • [0051]
    [0051]FIG. 18A is a bottom view of the needle of FIG. 15A;
  • [0052]
    [0052]FIG. 19 is a perspective view of a surgical instrument particularly suitable for use on a left side of a patient's body, according to one aspect of the present invention;
  • [0053]
    [0053]FIG. 20 is an end view of the needle of FIG. 19;
  • [0054]
    [0054]FIG. 21 is a front view of the needle of FIG. 19;
  • [0055]
    [0055]FIG. 22 is a bottom view of the needle of FIG. 19;
  • [0056]
    [0056]FIG. 19A is a perspective view of a surgical instrument particularly suitable for use on a left side of a patient's body, which needle is similar, but not identical to the needle of FIG. 19;
  • [0057]
    [0057]FIG. 20A is an end view of the needle of FIG. 19A;
  • [0058]
    [0058]FIG. 20B is an end view of another embodiment of needle according to the present invention;
  • [0059]
    [0059]FIG. 21A is a front view of the needle of FIG. 19A;
  • [0060]
    [0060]FIG. 22A is a bottom view of the needle of FIG. 19A,
  • [0061]
    [0061]FIG. 23 is a perspective view of a short dilator for use in accordance with an aspect of the present invention;
  • [0062]
    [0062]FIG. 23A is a sectional view of another embodiment of dilator in proximity with another embodiment of a needle.
  • [0063]
    [0063]FIG. 23B is a sectional view of another version of a dilator and the needle of FIG. 23A.
  • [0064]
    [0064]FIG. 23C is a sectional view of another embodiment of a dilator and needle combination.
  • [0065]
    [0065]FIG. 24 is an enlarged, sectional view of an internal portion of the dilator of FIG. 23 in accordance with an aspect of the present invention;
  • [0066]
    [0066]FIG. 25 is sectional view of the dilator of FIG. 23 in accordance with an aspect of the present invention;
  • [0067]
    [0067]FIGS. 25A and 26 are another sectional view of the dilator of FIG. 23 illustrating different features;
  • [0068]
    [0068]FIG. 26A is a sectional view illustrating a specially designed distal region of a needle inserted into the dilator of FIG. 25;
  • [0069]
    [0069]FIG. 27 is a side view of a distal region of a needle according to the present invention; showing a specially designed shape that is complementary to inner surfaces of the dilator of FIG. 23;
  • [0070]
    [0070]FIG. 28 is a perspective view of one embodiment of a sling assembly according to the present invention;
  • [0071]
    [0071]FIG. 29 is a side view of the sling assembly of FIG. 28;
  • [0072]
    [0072]FIG. 30 is a side view of a sling and tensioning suture according to an aspect of the present invention;
  • [0073]
    [0073]FIG. 31 is a schematic illustration of anatomical features, showing a pubic bone with dashed lines and incisions;
  • [0074]
    [0074]FIG. 32 is a schematic illustration of the relative positions of the patient's pubic bone and a novel needle according to the present invention, after at least partially inserting the needle;
  • [0075]
    [0075]FIG. 33 is a schematic illustration of the relative positions of the patient's pubic bone and a novel needle according to the present invention, after at least partially inserting the needle;
  • [0076]
    [0076]FIGS. 34 through 38 are perspective views sequentially showing a surgical procedure in accordance with another aspect of the present invention, wherein:
  • [0077]
    [0077]FIG. 34 shows a needle just passing an incision on the right side of a patient's body with the tip of the needle shown in dotted lines;
  • [0078]
    [0078]FIG. 35 illustrates a needle just passing an incision on the left side of a patient's body with the tip of the needle and part of the surgeon's finger shown in dotted lines;
  • [0079]
    [0079]FIG. 36 illustrates one side of a sling assembly and the needle of FIG. 35 as it emerges from the patient's vagina;
  • [0080]
    [0080]FIG. 37 shows the sling assembly of FIG. 36 after it is attached to the needle of FIG. 36;
  • [0081]
    [0081]FIG. 38 is a perspective view of a sling assembly being pulled through the body by a needle in accordance with the present invention;
  • [0082]
    [0082]FIG. 39 is a perspective view of a design of a surgical instrument according to another aspect of the present invention;
  • [0083]
    [0083]FIG. 40 is a top view of the instrument of FIG. 39;
  • [0084]
    [0084]FIG. 41 is a bottom view of the instrument of FIG. 39;
  • [0085]
    [0085]FIG. 42 is a front view of the instrument of FIG. 39;
  • [0086]
    [0086]FIG. 43 is a rear view of the instrument of FIG. 39;
  • [0087]
    [0087]FIG. 44 is a right end view of the instrument of FIG. 39;
  • [0088]
    [0088]FIG. 45 is a left end view of the instrument of FIG. 39;
  • [0089]
    [0089]FIG. 46 is a perspective view of a design of a instrument according to another aspect of the present invention;
  • [0090]
    [0090]FIG. 47 is a top view of the instrument of FIG. 46;
  • [0091]
    [0091]FIG. 48 is a bottom view of the instrument of FIG. 46;
  • [0092]
    [0092]FIG. 49 is a front view of the instrument of FIG. 46;
  • [0093]
    [0093]FIG. 50 is a rear view of the instrument of FIG. 46;
  • [0094]
    [0094]FIG. 51 is a right end view of the instrument of FIG. 46;
  • [0095]
    [0095]FIG. 52 is a left end view of the instrument of FIG. 46;
  • [0096]
    [0096]FIG. 53 is a perspective view of a system for use in an inside out procedure according to the present invention that includes a portion that is at least partially reusable;
  • [0097]
    [0097]FIG. 54 is a perspective view of a universal system capable of use in inside-out and outside in approaches according to the present invention, which system includes a needle having two regions capable of attachment to either a handle or a sling assembly;
  • [0098]
    FIGS. 55-57 sequentially illustrate use of the system of FIG. 54 wherein:
  • [0099]
    [0099]FIG. 55 illustrates passage of the needles using inside-out approaches,
  • [0100]
    [0100]FIG. 56 illustrates the needles after the handles have been removed, in preparation for attachment of a sling assembly on the regions of the needles previously occupied by the handles;
  • [0101]
    [0101]FIG. 57 illustrates the system during implantation of the sling;
  • [0102]
    [0102]FIG. 58 is a schematic illustration of the system of FIG. 54 used in an inside-out approach (the right side of the patient) and an outside-in (the left side of the patient) approach;
  • [0103]
    FIGS. 59-61 sequentially illustrate the system of FIG. 54 used in outside-in approaches wherein:
  • [0104]
    [0104]FIG. 59 illustrates the needles inserted initially through the patient's skin and thereafter emerging from a vaginal incision;
  • [0105]
    [0105]FIG. 60 illustrates the system just prior to attachment of a sling assembly,
  • [0106]
    [0106]FIG. 61 illustrates the system of FIG. 54 during implantation of the sling;
  • [0107]
    [0107]FIG. 62 is a perspective view of another embodiment of surgical assembly according to the present invention, with a needle suitable for an outside-in approach (e.g. on the left side of the patient's body) and a sling assembly with a needle attached thereto suitable for an inside-out approach (e.g. through the right side of the patient's body);
  • [0108]
    [0108]FIG. 63 is a perspective view of an alternative embodiment of sling assembly for use in accordance with the present invention;
  • [0109]
    [0109]FIG. 64 is a perspective view of an alternative embodiment of sling assembly for use in accordance with the present invention, which assembly does not include a sheath;
  • [0110]
    [0110]FIG. 65 is a perspective view of an alternative embodiment of sling assembly for use in accordance with the present invention;
  • [0111]
    [0111]FIG. 66 is a top plan view of an alternative embodiment of sling assembly for use in accordance with the present invention; and
  • [0112]
    [0112]FIG. 67 is a top plan view of an alternative embodiment of sling assembly for use in accordance with the present invention.
  • [0113]
    The broken line showing of structures on the design of the surgical instruments in FIGS. 39 through 52 are for illustrative purposes only and form no part of the claimed design.
  • DETAILED DESCRIPTION
  • [0114]
    The following description is meant to be illustrative only and not limiting. Other embodiments of this invention will be apparent to those of ordinary skill in the art in view of this description.
  • [0115]
    The present invention is directed to surgical instruments, assemblies and implantable articles for treating pelvic floor disorders such as incontinence or stress urinary incontinence (SUI) in both men and women. The present invention is also directed to improved surgical procedures that utilize the surgical articles.
  • [0116]
    [0116]FIG. 1 is a side view of a sling assembly guide or needle 60 according to one aspect of the present invention. The needle 60 is preferably sized and shaped to be suitable for initial insertion through obturator fascia (see FIGS. 4 through 8). The needle 60 has a length sufficient to extend from the initial incision 400 adjacent the anterior side of the pubic bone, through the obturator foramen 3 (e.g. see FIG. 9) portion of the pubic bone to a position on the posterior side of the pubic bone, and to then emerge from a vaginal incision. While FIG. 1 is a side view or a species of the present invention, the present invention is not limited to the particular shape disclosed. It is expressly understood that a large number of different sizes, shapes and dimensions of needles are suitable for the present invention.
  • [0117]
    There are many vulnerable, sensitive pelvic anatomical structures and tissues in the region of the obturator foramen 3, including the pudendal artery (internal), the pudendal canal (Alcock), and nerves (e.g. the perineal and labial). The needle 60 is preferably sized and shaped to pass through the obturator foramen 3 along a path that is substantially free of vascular and nerve structures. The size and shape of the needle 60 help avoid the sensitive structures. For example, in one embodiment, the path may be in a region between the superior pubic ramus and the inferior pubic ramus (see e.g. FIGS. 4 through 10). The tip of the needle is preferably substantially blunt to help avoid damage to the sensitive structures. Alternatively, the tip may be slightly sharpened to assist in the initial passage of the needle.
  • [0118]
    Preferably, the needle 60 comprises three substantial linear portions 60A, 60B and 60C; each situated at an angle relative to the other linear portions. Preferably, the angles are different. The needle 60 preferably includes a leading portion 60A, an intermediate portion 60B and a trailing portion 60C.
  • [0119]
    The leading portion 60A of the needle 60 is sized to extend through the initial incision 400. The cross-sectional shape of the needle 60 is preferably substantially circular, but other cross sectional shapes such as, but not limited to, elliptical, polygonal, square and triangular are also contemplated herein. The diameter of the leading portion 60A is less than 5 mm, more preferably less than 4 mm, and even more preferably less than 3.5 mm to avoid damaging or displacing tissue. The sudden angle between the intermediate portion 60B of the needle and the leading portion 60A helps the surgeon avoid sudden lurches of the needle after the region 58 passes through the obturator fascia, as the intermediate 60B or trailing 60C portions of the needle can be grasped or abut external portions of the patient to stop an undesirable, sudden lurch through tissue. The angle also helps the surgeon steer the needle 60 along a desired or predetermined path.
  • [0120]
    The angle between the intermediate portion 60B and the trailing portion 60C is preferably greater than ninety degrees, more preferably, it is greater than one hundred and twenty degrees. The length of the trailing portion 60C should be sufficient to allow the surgeon to leverage the end of region 58 of the needle and drive it along its predetermined, desired path. This geometry helps direct the end of the region 58 back toward the surgeon. This geometry also helps the surgeon pass the needle through this portion of the body and emerge from the vagina without undue tissue trauma.
  • [0121]
    [0121]FIG. 3 illustrates a kit 15 according to an aspect of the present invention. The kit 15 preferably comprises an implantable material (e.g. a sling mesh provided as part of a sling assembly 46), at least one (preferably two) optional handle 64, and at least one (preferably two) needle 60.
  • [0122]
    The handle 64 is entirely optional. The handle may be removably attached to the needle, or it may be repositionably attached to the needle. Alternatively, the handle may be permanently attached to the needle 60. FIGS. 13 and 14 illustrate an optional shape of handle 64A suitable for permanent attachment to the needle 60. Other suitable handles are disclosed, for example, in U.S. Provisional Patent Application Nos. 60/347,494; 60/336,884 and 60/343,658.
  • [0123]
    The needle 60 is preferably made of a durable, biocompatable surgical instrument material such as, but not limited to, stainless steel (e.g. 316 stainless steel or 17-4 stainless steel), titanium, Nitinol, polymers, plastics and other materials, including combinations of materials. The needle 60 should have sufficient structural integrity to withstand the various forces (e.g. forces caused by dilator attachment, and penetration/passage of the needle 60 through the various tissues) without undergoing any significant structural deformation. Optionally, the needles 60 could be sufficiently malleable to allow a practitioner or user of the device to modify the needle 60 to a desired shape and, thereby, optimize the procedural approach.
  • [0124]
    Needles 60 may be disposable or reusable (e.g. sterilizable by steam sterilization procedures). In another aspect of the present invention, the needles 60 may be provided in a kit, such as any of the kits described in any of published U.S. patent application Ser. Nos. 2002-0151762-A1; 2002-0147382-A1; 2002-0107430-A1, US-2002-0099258-A1and No. US-2002-0099259-A1; and U.S. Provisional Application Serial Nos. 60/263,472, filed Jan. 23, 2001; 60/269,829, filed Feb. 20, 2001; 60/281,350, filed Apr. 4, 2001; 60/295,068, filed Jun. 1, 2001; 60/306,915, filed Jul. 20, 2001, and U.S. Provisional Patent Application No. 60/332,330, filed Nov. 20, 2001.
  • [0125]
    One embodiment of kit includes the needle 60 and other needles (not shown, but for example including the needles shown in published U.S. patent application Ser. No. US-2002-0099258-A1) designed for placing a sling from the abdominal rectus fascia, under the urethra, and then back to the rectus fascia. If a traditional pubovaginal sling procedure seems to be an option for a patient but, during or prior to the surgical procedure, it becomes apparent that excessive scar tissue (e.g. due to a previous surgery) exists and would render the traditional procedure less desirable or impossible, then the needle 60 may be used in an alternative approach. Since the needles 60 are also provided in a kit, the surgeon has the option of conducting an alternative surgical procedure with the needles 60.
  • [0126]
    In another aspect of the present invention, a needle may optionally include the capacity to deliver a medicament (e.g. anesthesia) during the surgical procedure. For example, the needle 60 may be hollow with an open end. The needle may have a connector for associating with a medicament reservoir and delivery mechanism (e.g. a syringe).
  • [0127]
    The present invention may be utilized in conjunction with a wide variety of sling materials and sling assemblies. The sling may be integral, monolithic, or a composite of different components or segments of different components. Suitable non-synthetic materials include allografts, homografts, heterografts, autologous tissues, cadaveric fascia, autodermal grafts, dermal collagen grafts, autofascial heterografts, whole skin grafts, porcine dermal collagen, lyophilized aortic homografts, preserved dural homografts, bovine pericardium and fascia lata. Suitable synthetic materials for a sling include polymerics, metals and plastics and any combination of such materials.
  • [0128]
    Commercial examples of non-absorbable materials include Marlex™ (polypropylene) available from Bard of Covington, R. I., Prolene™ (polypropylene) and Mersilene (polyethylene terphthalate) Hernia Mesh available from Ethicon, of New Jersey, Gore-Tex™ (expanded polytetrafluoroethylene) available from W. L. Gore and associates, Phoenix, Ariz., and the polypropylene sling available in the SPARC™ sling system, available from American Medical Systems, Inc. of Minnetonka Minn. Commercial examples of absorbable materials include Dexon™ (polyglycolic acid) available from Davis and Geck of Danbury, Conn., and Vicryl™ available from Ethicon. Other examples of suitable materials include those disclosed in U.S. patent application Ser. No. 2002/0072694. More specific examples of synthetic sling materials include, but are not limited to polypropylene, cellulose, polyvinyl, silicone, polytetrafluoroethylene, polygalactin, Silastic, carbon-fiber, polyethylene, nylon, polyester (e.g. dacron) PLLA and PGA. The sling material may be resorbable, absorbable or non-absorbable. Optionally, some portions may be absorbable and other portions may be non-absorbable.
  • [0129]
    The synthetic slings may be knitted, woven, sprayed or punched from a blank. Some slings may be sufficiently robust to be inserted without a protective sleeve. In other embodiments, some synthetic slings may have an associated protective sleeve (described in greater detail below) to assist with the implantation.
  • [0130]
    In one aspect of the invention, the sling may comprise a mesh material. The mesh material comprises one or more woven, knitted or inter-linked filaments or fibers that form multiple fiber junctions throughout the mesh. The fiber junctions may be formed via weaving, knitting, braiding, bonding, ultrasonic welding or other junction forming techniques, including combinations thereof. In addition, the size of the resultant openings or pores of the mesh may be sufficient to allow tissue in-growth and fixation within surrounding tissue. As an example, not intended to be limiting, the holes may comprise polygonal shaped holes with diagonals of 0.132 inches and 0.076 inches.
  • [0131]
    The quantity and type of fiber junctions, fiber weave, pattern, and material type influence various sling properties or characteristics. As another example, not intended to be limiting, the mesh may be woven polypropylene monofilament, knitted with a warp tricot. The stitch count may be 27.5 courses/inch (+or−2 courses ) and 13 wales/inch (+or−2 wales). The thickness of this example is 0.024 inches. This embodiment of sling is preferably associated with a protective sleeve (described in greater detail below). Non-mesh sling configurations are also included within the scope of the invention.
  • [0132]
    Referring to FIGS. 29 and 30, the sling mesh 42A is preferably elastic, as opposed to the substantially inelastic mesh available in Europe as UratapeŽ from Porges, and the tape described in Published U.S. patent application Ser. No. 2002/0099260. As an example, a mesh may be tested to determine whether it is elastic using a series IX Automated Materials Testing System (an Instron), available from Instron Corporation. A 1 cm wide sample of the mesh may be placed in the Instron with a crosshead speed set at 5 in/min and a gauge length of 1 inch. An elastic mesh exhibits at least a 7% elongation under a ˝ pound load, more preferably about a 10% elongation under a 2 pound load, and more preferably about 14% under the ˝ pound load; An inelastic mesh exhibits less than an 7% elongation under a ˝ pound load.
  • [0133]
    The mid-portion of the sling mesh (the portion designed to reside underneath the midurethra) is preferably substantially free of any silicone coatings. In yet another embodiment (e.g. shown in FIG. 28), the mid-portion of the sling may comprise a non-synthetic material, constructed according to the teachings of U.S. Provisional Patent Appl. No. 60/405,139, filed Aug. 22, 2002. Other suitable synthetic slings are described in published U.S. Pat. No. 2002-0138025-A1, published Sep. 26, 2002.
  • [0134]
    In another embodiment the sling material may have one or more substances associated therewith through a process such as coating or they may be incorporated into the raw material of the sling. Examples of appropriate substances include, without limitation, drugs, hormones, antibiotics, antimicrobial substances, dyes, silicone elastomers, polyurethanes, radiopaque filaments or substances, anti-bacterial substances, chemicals or agents, including any combinations thereof The substances may be used to enhance treatment effects, reduce potential sling rejection by the body, reduce the chances of tissue erosion, enhance visualization, indicate proper sling orientation, resist infection or other effects.
  • [0135]
    While the slings are preferably rectangular for treating SUI in females, other shapes are also contemplated. Depending on the treatment addressed (e.g. to provide hammock support for the bladder or bladder neck, or to address a rectocele, enterocele or prolapse) the slings may be any of a wide variety of shapes. As an example, the sling may be of the general shape of the slings described and shown in Moir et al., The Gauze-Hammock Operation, Journal of Obstetrics and Gynaecology of the British Commonwealth, Volume 75, No. 1, Pps. 1-9 (1968).
  • [0136]
    [0136]FIG. 12 shows a sling 90 with a shape other than a purely rectangular shape. This embodiment of sling 90 includes a mid portion that is wider than the remaining portions of the sling 90. The mid portion is preferably placed under the urethra 16, along the mid portion of the urethra.
  • [0137]
    [0137]FIG. 2 illustrates a sling assembly 46 comprising sling 42 and sheath 44. Preferably, the overall dimensions of the sling assembly 46, including insertion sheath 44 and sling 42 are sufficient to extend from a superficial incision 400 near the obturator fascia (see FIGS. 4 through 8), to an undersurface of the urethra 16 and back to another incision 400 in obturator fascia that is opposite the first incision. The size of the sling can take into account the imprecision associated with the range of human anatomy sizes. In a preferred embodiment, the sheath length of the assembly of the present invention is approximately within the range of 10 cm to 50 cm, sheath width is approximately within the range of 1.0 cm to 2 cm, and sheath material thickness is approximately within the range of 0.127 mm to 0.203 mm, respectively. The associated sling 42 has a length, width and thickness approximately within the range of 7 cm to 50 cm; 1.0 cm to 2 cm; and 0.508 mm to 0.711 mm, respectively.
  • [0138]
    The sling 42 of the present invention can be implanted without the need for bone screws. The precise, final location of the sling 42 will depend on a variety of factors including the particular surgical procedure(s) performed, and any preconditions of the patient such as scar tissue or previous surgeries. For example, it may be preferred to place the sling 42 in close proximity to, but not in contact with, a mid portion of the urethra to treat incontinence. Alternatively, the sling may be placed near the bladder neck.
  • [0139]
    Preferably, the sling 42 has a tensioning filament or suture T as disclosed, for example, in U.S. Published patent application Ser. No. US-2002-0107430-A1. The tensioning suture T may be constructed from a permanent or absorbable material. Also preferably, the sling 42 comprises a substantially elastic, polypropylene sling such as a sling constructed from the polypropylene sling material available in the SPARC Sling System, available from American Medical Systems of Minnetonka, Minn.
  • [0140]
    [0140]FIG. 30 illustrates an embodiment with the tensioning filament T extending along end portions, but not extending along a mid-portion of the sling. The sling 42A comprises a polypropylene sling mesh 42A. It is constructed of polypropylene monofilament that is precut to about 1.1 cm width×35 cm length. The tensioning filaments T in this embodiment are fixed at each end to the sling material (e.g. a polypropylene mesh) by welding (e.g. ultrasonic), knotting, anchoring, adhering (e.g. with and adhesive) or the like. Absorbable tensioning sutures T are threaded into the length of the sling mesh 42A from each end to allow for tensioning adjustment of the sling mesh 42A after placement in the patient is achieved. The mid portion of the sling mesh 42A is preferably free of the tensioning sutures T. For example, approximately 5 mm may separate the ends of the two tensioning sutures T.
  • [0141]
    Two plastic sheaths 44A (see FIG. 29) that overlap in the center of the sling mesh cover the sling mesh and protect it during placement. The plastic covering over the mesh is designed to minimize the risk of contamination.
  • [0142]
    Referring to FIG. 2, a protective sheath 44 is preferred, especially when the sling 42 is elastic. A sheath is particularly desirable when the sling is elastic as the sheath 44 assists in introduction of the sling within tissue and avoids damage to the elastic sling material. The sheath 44 is used during insertion of a synthetic sling 42. After the sling 42 is implanted, the sheath 44 is removed and discarded. Preferably, the protective sheath 44 is constructed of a material that affords visual examination of the implantable sling material 42 and that affords convenient passage of the assembly 46 through tissue of the patient.
  • [0143]
    In a preferred embodiment, the sheath 44 is made of polyethylene. Other materials including, without limitation, polypropylene, nylon, polyester or Teflon may also be used to construct the sheath 44. The sheath 44 should also conveniently separate from the sling material 42 after the sling 42 is implanted without materially changing the position of the sling 42.
  • [0144]
    The sheath 44 may comprise two elongate, separable sections. Optionally, portions of the sheath 44 may detachably and telescopically overlap near the middle portion of the sling or it may be slit (e.g. longitudinally or perpendicular to the longitudinal axis) to afford convenient separation.
  • [0145]
    In another aspect, the present invention comprises a dilator 54 (FIG. 2) for use in a surgical sling procedure. Notably, the dilator is optional according to some aspects of the present invention as, for example, the sling and/or protective sheath may be directly connected to a novel needle of the present invention by virtue of an eyelet in the needle or other arrangements disclosed in greater detail below.
  • [0146]
    The dilator 54 comprises a body portion having first end portion 56 and second end portion 52 opposite the first end portion 56. The first end portion 56 has surfaces for associating the dilator with a needle (e.g. region 58 of needle 60). The second end portion 52 has sling association means for associating the article with a sling, sling assembly or component thereof. The sling association means may comprise a hole 90.
  • [0147]
    Preferably, the dilator 54 comprises a short article that dilates a needle track for ease of sling introduction and positioning within the patient. Region 58 of the needle 60 is preferably keyed to allow for convenient, secure attachment of the needle 60 relative to the dilator 54. Preferably the attachment is permanent.
  • [0148]
    The kit shown in FIG. 3 includes two dilators 54. The dilators 54 atraumatically create and/or expand the passageway through the tissues for sling assembly delivery. The dilator 54 is preferably short relative to a needle 60 for ease of passage of the assembly and to reduce the overall amount of tissue that is deflected at one time. Preferably, the dilator is less than 2.5 inches in length, and more preferably, it is less than one inch in length, even more preferably, it is less than 0.7 inches in length. The maximum radius of a dilator 54 is preferably less than 10 mm, more preferably less than 7.5 mm, even more preferably less than about 5 mm. The tip or leading end of the dilator 54 is preferably blunt, as, in preferred embodiments, the leading tip of the dilator 54 will pass through tissue that has already been pierced by a needle 60. The dilator 54 may be made from a variety of biocompatible and sterilizable materials including, without limitation, acetal, polycarbonate, polypropylene, DelrinŽ, Acrylonitrile-Butadiene-Styrene (ABS), polyethylene, nylon and any combination of biocompatible materials.
  • [0149]
    The dilator 54 preferably includes means for associating with a surgical needle 60. In a preferred embodiment, the association means affords a permanent affixation between the dilator 54 and the needle 60. By “permanent affixation”, it is meant that it would be very difficult to manually separate the dilator from the needle after they have become permanently affixed. After implantation of the sling 42, to separate the sling 42 from the dilator 54/needle 60, the surgeon cuts an end of the sling 42 as described more fully below. The association means preferably affords quick and convenient attachment of the dilator 54 to the needle 60 to avoid wasting time in the midst of a surgical procedure. The attachment should also be secure to avoid separation of the needle 60 and dilator 54 while the combination is passed through tissue.
  • [0150]
    In one embodiment, the means comprises a shoulder surface on the needle and complementary slot surfaces on the dilator 54. Referring to the embodiment of dilator shown in FIG. 2, the dilator 54 may be approximately 3.1 cm (1.2 inches) in length. The dilator 54 preferably includes a gentle taper near its first end 56. The dilator is sized and shaped to provide atraumatic passage through body tissue. The taper and relatively smooth outer surface of the dilator 54 facilitate atraumatic passage of the dilator 54 and attached sling assembly 46 through the various tissues of the patient. The presence of the dilator 54 allows a gentle transition between the diameter of the needle, to the shape of the dilator, and finally to the sling assembly 46.
  • [0151]
    Preferably, the attachment of the dilator 54 to the needle 60 is a substantially linear fashion, as opposed to a twisting or screw-like attachment. Preferably, the attachment is a snap-fit attachment to save time during the surgical procedure.
  • [0152]
    The second end 52 of the dilator 54 associates the dilator with one end of a sling 42, or sheath 44 or sling assembly 46. The sheath 44 or sling 42 is preferably attached to the dilator 54 via a first opening or through-hole located near the second end 52 of the dilator 54. In this embodiment, the opening operates as a universal sling material or assembly attachment point which can receive a variety of materials, such as fascia, autologous materials, synthetics, biologic tissues and any other similar tissues, including any combinations.
  • [0153]
    In the embodiment shown in FIG. 2, the end portion 48 or 50 of one end of the sheath 44 is threaded through the opening of the dilator 54 and secured to the sheath 44, thereby forming a loop. Alternatively, ends 48 or 50 may be fastened onto the sheath 44 via ultrasonic welding, bonding, melting, suturing, sealing or other attachment techniques. Further, the end 52 of the dilator 54 preferably includes a cut-away section to provide room to receive sling assembly material to reduce the overall profile of the sling assembly experienced by tissue during sling passage. Therefore, when the sheath is attached to the cut-away section, the additional sheath material is not apt to significantly increase the relative thickness, diameter or profile of the dilator 54. Unlike the showing in FIG. 3, the dilator 54 is preferably preattached to the sling assembly 46. In one embodiment, the sling 42 itself may be attached to the dilator, e.g. with a suture threaded through the opening of the dilator and tied to the sling.
  • [0154]
    One or more longitudinal slots located on the outer surface of the dilator 54 allow the wall of the dilator 54 to expand in a radially outward direction when the first end of the needle 60 is inserted into the opening of the dilator 54. When a shoulder of the dilator 54 passes the recess of the needle 60, the wall of the dilator 54 collapses around the needle 60 as the shoulder seats into the recess, thereby securing the dilator 54 on the needle 60 and blocking separation of the dilator 54 and needle 60.
  • [0155]
    A portion of the dilator 54 includes a taper having a decreasing profile toward the second end 56 of the dilator 54. The taper preferably gently cams tissue out of the path of the sling assembly 46 as the sling assembly is inserted in the body. The taper is also sized and shaped to reduce the amount of friction or resistance as the device is drawn through the tissues of the patient. The amount of force required to manipulate the device through the tissues is thereby reduced. This in turn provides the user of the assembly with additional control over device insertion and maneuverability through tissue and within the patient. In addition to tapered profiles, other dilator profiles such as conical, flared, frusto-conical, pyramid-shaped, elliptical or other applicable profiles may also be used.
  • [0156]
    A surgical kit according to the present invention may optionally include additional accessories. For example, a surgical drape specifically designed for urological procedures such as a sling procedure may be included in a kit of the present invention. Such a drape is disclosed in published U.S. patent application Ser. No. 2002-078964A1. Alternatively, an article for objectively setting tension of the sling, such as one of the articles described in U.S. patent application Ser. No. 09/968,239, filed Oct. 1, 2001 may be included in the kit.
  • [0157]
    The kits according to the present invention preferably include at least two needles. In some instances the needles may be substantially identical, in other instances, they may be different. Two or more needles reduce the need to reuse a non-sterile needle at a different location with a patient, thereby eliminating cross contamination issues. Additional needles, handles, dilators and other elements may also be included for surgical convenience, for avoidance of contamination from one portion of the body to another, for ease of manufacturing or sterilization or for surgical requirements. For example, two different types of needles may be included in a kit. One type of needle may be suitable for an outside-in (e.g. from the skin incision toward a vaginal incision) approach. Another type may be suitable for an inside-out (e.g. from the vaginal incision toward a skin incision) approach. Surgeons that prefer an approach dictated by the surgeon's dominant hand may prefer this embodiment. Alternatively, a universal needle (e.g. one suitable for both an inside out and an outside in approach) may be utilized.
  • [0158]
    [0158]FIG. 53 illustrates a system 101 for use in an inside-out procedure. The system 101 comprises a pair of needles 109 that are sized and shaped for the inside-out approach. The system 101 also includes a sling assembly comprising a sling 111, and protective sheath 113. The sling assembly may be permanently attached to the needles 109 at regions 117. Alternatively, the needle 109 can include specially shaped structure (e.g. an eyelet) in region 117 that affords association between the needle 109 and sling or sling assembly after passage of the needle 109. The system 101 may optionally include releasable handle portions 119 that can be releasably attached to the needles 109 at ends 121.
  • [0159]
    [0159]FIG. 54 illustrates a system 102 for use in either an inside-out procedure or an outside-in procedure. The system 102 comprises a sling assembly 146 having a sling material 142, a sheath 144 and dilators 154. The system includes a handle portion 164 that is at least partially reusable. Needles 162 are suitable for either an inside-out or outside in procedure. The regions 158 of the needles 162 may be attachable to either a dilator 154 or the handle portion 164. Alternatively, the needles may be attachable to the implantable material itself or a sling and protective sleeve assembly without any dilator.
  • [0160]
    The system 102 allows the needles to be passed through tissue without requiring that they be attached to a sling or sling assembly. Thus, if the initial passage is not deemed to be optimum, the needles may be repassed without subjecting the sling or sling assembly to damage during the initial passage.
  • [0161]
    FIGS. 55-57 sequentially illustrate use of the system 102 using an inside-out approach. FIG. 55 illustrates passage of the needles 162 using inside-out approaches. The handles 164 are optional. If they are used, they are removed once the needles 162 have emerged from the skin incision. FIG. 56 illustrates the needles 162 after the handles 164 have been removed, in preparation for attachment of a sling assembly 146 on the regions 158 of the needles 162 previously occupied by the handles 164. FIG. 57 illustrates the system 102 during implantation of the sling.
  • [0162]
    [0162]FIG. 58 is a schematic illustration of the system 102 used in an inside-out approach (the right side of the patient) and an outside-in (the left side of the patient) approach. This combination may be utilized, by a right-handed surgeon who prefers to pass the leading edge of the needle with his or her dominant hand. Alternatively, the combination may be reversed for a left-handed surgeon. The remainder of the surgical procedure may be substantially identical to that depicted in FIGS. 56 and 57. Notably, the handle 164 utilized on the right side of the patient's body may optionally be placed on the other side of the needle after it emerges from the patient's body to conveniently assist the surgeon in moving the needle 162 and sling assembly 146 through the tissue.
  • [0163]
    FIGS. 59-61 sequentially illustrate the system 102 used in outside-in approaches. FIG. 59 illustrates the needles 162 inserted initially through the patient's skin and thereafter emerging from a vaginal incision. FIG. 60 illustrates the system 102 just prior to attachment of a sling assembly 146. FIG. 61 illustrates the system 102 during implantation of the sling.
  • [0164]
    Referring to FIG. 62, there is shown another system 200 according to the present invention. The system 200 comprises a needle 262 suitable for an outside-in approach on the left side of the patient's body and associated handle 264. The system 200 also includes a sling assembly 246 comprising a sling 242, protective sheath 244 and dilator 254 at one region. The dilator 254 is designed to mate with the region 258 of the needle 262. At the other end of the sling assembly 246, a needle 265 may be permanently attached to the sling assembly 246. The needle 265 is sized and shaped to be suitable for an inside-out approach on the right side of a patient's body. The needle 265 includes a leading region 266 suitable for that purpose. The leading region 206 may include a portion that is blunt or, alternatively somewhat sharpened. The system 200 is particularly suitable for a surgeon that desires to initially pass needles with his or her dominant hand. The depicted system 200 is suitable for a right-handed surgeon. A mirror image or reverse system is particularly suitable for a left-handed surgeon that desires to initially pass a needle with his or her left hand.
  • [0165]
    Optionally, the system 200 could include a detachable handle for the needle 265 to assist in passage of the needle 265. Also optionally, the needle 264 may be omitted from the system. Instead, the needle 265 may be used to pass the sling initially using an outside-in approach on one side of the body and then continuing to insert the sling using an inside out approach on the other side of the body.
  • [0166]
    In a preferred embodiment, a kit comprises two surgical instruments such as those shown in FIGS. 15-22, and a polypropylene sling mesh assembly with attached dilators as shown in FIG. 28. Such a kit may be provided for the placement of a pubourethral sling for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
  • [0167]
    In a further preferred embodiment, a dilator used for associating the sling with the surgical instrument is shown in FIG. 23A. Dilator 54 is shown having a diameter X that is substantially the same as the diameter x of the needle 60. By making the diameter of the dilator the substantially the same size as that of the needle, the system can avoid subjecting tissue to a sudden discontinuity as it moves through tissue. This low profile can assist in effectively and efficiently implanting the sling material. In FIG. 23B, the dilator is shown having a diameter that matches the diameter of the needle at one end thereof, and gets larger towards the other end. In FIG. 23C, another low profile dialator and needle combination is shown. In this further low profile embodiment, any flats on the needle and on the mating surfaces within the connector have been removed. The removal of any flats allows the needle and connector to be quickly and easily connected without worrying about proper orientation of the connector relative to the needle. This embodiment also allows the connector to rotate during passage within the body and thus may decrease the resistance of the passage of the needle once the connector has been attached to the needle end. In addition, the needle end is recessed and the connector's leading edge may be hidden in this recess rather than extending beyond the diameter of the needle. This embodiment avoids any exposed edge or lip at the interface of the connector and needle. The smaller profile further provides less dilation by the connector during withdrawal and reduces the resistance to withdrawal of the needle once the connector has been attached. Still further, the smaller connector creates a smaller opening the body during passage which may aid in the anchoring of the sling into the area of deployment. The smaller channel that the sling is placed in may provide greater anchoring forces on the sling immediately after deployment and before ingrowth. Finally the overall amount of the connector that extends beyond the tip of the needle and the overall length of the connector is shortened in this embodiment. Because the connector is relatively straight, any amount that the connector extends beyond the tip of the needle may actually increase the resistance during withdrawal and may actually result in more trauma and dilation to the tissue than may be desired.
  • [0168]
    The individual elements of the kits of the present invention may be packaged together, separately or in subassemblies depending on a variety of factors such as shelf life and sterilization requirements. They may be assembled at the manufacturing location or at the healthcare location. Any suitable sterilization procedure may be utilized to sterilize the contents of a kit. Suitable sterilization techniques include, but are not limited to steam, ethylene oxide, electron beam, vapor (e.g. hydrogen peroxide or peracetic acid), gamma or plasma procedures. For example, the surgical instrument may be reusable or single use devices.
  • [0169]
    [0169]FIG. 11 shows another embodiment of the present invention. The FIG. is schematic and is not to scale. Some features are exaggerated or omitted to illustrate or emphasize other details. For example, the vaginal incision is only shown schematically and should not be interpreted as identifying a preferred size, shape or location of the incision.
  • [0170]
    In this embodiment, the needle 60 acts as a surgical guide needle (e.g. with a diameter of about 4 mm, or less, preferably about 3 mm) for a relatively larger sling transport needle 604 (e.g. with a diameter of about 5 mm or less). Preferably, the sling transport member has a sling assembly 610 (e.g. a sling mesh and insertion sheath) attached thereto. Alternatively, the sling transport needle 604 may have a more exaggerated hook shape, similar to the shape shown in PCT WO 02/39890.
  • [0171]
    The guide needle 60 serves a different purpose than the surgical transport needle 604. The surgical guide needle 60 is preferably small and has a blunt tip. The blunt tip is initially inserted through incision 400 adjacent obturator fascia and then through a vaginal incision. Inserting a small, blunt needle in this fashion provides the surgeon with additional control in maneuvering through the anatomy of a patent and in avoiding sensitive tissue.
  • [0172]
    A surgical kit according to an aspect of the present invention may include a dilator 54 for placement on a tip of needle 60. The sling transport needle 604 may optionally include a sharp tip. The dilator 54 receives the tip of the needle 604. A technique of pushing sideways on the sling transport needle 604 with one hand while steering the tip of the needle 604 by holding guide needle 60 with the other hand may be used to implant the sling.
  • [0173]
    Alternatively, the dilator 54 may include surfaces for firmly engaging and attaching to needle 604. Those surfaces can include mechanical interlocking structures, grasping structures or interlocking structures. As a result, the needle 60 need not have specially shaped surfaces 58 for engaging the dilator and can instead have cylindrical surfaces adapted to be received within the dilator.
  • [0174]
    Referring to FIGS. 15, 16, 17 and 18, there is shown a novel needle 60R according to the present invention. The needle 60R is particularly suitable for passage on the right side of a patient's body, initially from an incision in the region of the patient's obturator foramen and subsequently emerging through a vaginal incision. The needle 60R includes a handle 64R and a leading region 62R. Referring to FIG. 27, the leading region 62R includes a substantially blunt distal tip 63R and specially designed surfaces 67R and 65R suitable for mating with complementary surfaces on a dilator or connector (described in more detail below). Notably, in one aspect of the present invention, a novel needle of the present invention may utilize an eyelet in the distal region to afford a suture attachment to a sling or sling assembly without the use of a dilator.
  • [0175]
    As shown in FIGS. 15-18, the needle 60R has substantial structure in three dimensions, as opposed to, for example, the substantially flat needle shown in FIG. 1 (or an Emmet needle) that only includes substantial structure in two dimensions. Having substantial structure in three dimensions helps the surgeon pass the needle through the obturator foramen and subsequently through a vaginal incision by affording greater surgeon control. The handle of the needle allows the surgeon to move the distal end of the needle with an ergonomic wrist roll action
  • [0176]
    [0176]FIGS. 15A, 16A, 17A and 18A show another embodiment of novel needle 60R′ that is similar, but not identical to the needle 60R. The needle 60R′ is also particularly suitable for passage on the right side of a patient's body, initially from an incision in the region of the patient's obturator foramen and subsequently emerging through a vaginal incision.
  • [0177]
    [0177]FIGS. 19, 20, 21 and 22 show another novel needle 60L according to the present invention. The needle 60L is particularly suitable for passage on the left side of a patient's body, initially from an incision in the region of the patient's obturator foramen and subsequently emerging through a vaginal incision. The needle 60L includes a handle portion 64L and a leading region 62L. Like the needle 60R, the needle 60R includes substantial structure in three dimensions.
  • [0178]
    [0178]FIGS. 19A, 20A, 21A and 22A show another embodiment of novel needle 60L′ that is similar, but not identical to the needle 60L. The needle 60L′ is also particularly suitable for passage on the left side of a patient's body, initially from an incision in the region of the patient's obturator foramen and subsequently emerging through a vaginal incision.
  • [0179]
    The instruments in FIGS. 15-22 are shown with indicator marks 66, 68 and 70. The indicator marks may be used by the surgeon to determine how far the need has been advanced into the patient. The indicator marks may, as examples, be mechanically or laser etched into the needle portion of the instruments. Marks may be placed at even spacings (e.g. every millimeter) to provide a visual measure of the distance the needle has been advanced. As an alternative, different regions of the needle may be color coded to provide a further visual indication to the surgeon of how far the needle has advanced into the patient.
  • [0180]
    Yet another embodiment of novel needle is shown in FIG. 20B. The novel needle 64L″ is substantially similar to the needle 64L′, except that the tip T of the needle lies substantially in the plane P of the handle H of the needle 64L″. It is believed that such an arrangement of the elements may assist some surgeons in conjuring a mental image of the location of the tip T of the needle 64L″ relative to the body while the needle is being passed through a patient outside the surgeon's direct vision. The arrangement of the tip and the handle affords visual feedback concerning the approximate location of the tip of the needle when the tip is not under direct vision. Instead of a snap-in feature for connection to a dilator, this needle 64L″ includes an eyelet E for threading a suture so that the needle 64L″ can be tied to an implantable material or assembly such as a knitted polypropylene sling with an associated sheath.
  • [0181]
    Further, as can be seen by FIGS. 17, 17A, the handle of the instrument has been marked with an indicator 72 to provide a visual indication for the surgeon of the rotational location of the tip 62 of the needle. Here, the visual indication is the letter T on the side of the handle on which the needle ends.
  • [0182]
    [0182]FIGS. 63 through 67 show various embodiments of sling assemblies suitable for use in the present invention. These assemblies may be used in systems that do not include a dilator. FIG. 63 illustrates a sling assembly 300 having sutures 306 for threading through an eyelet of a needle to associate the assembly 300 with a needle. The assembly 300 may comprise a composite assembly with synthetic portions 308 and a non-synthetic mid portion 309 connected with fasteners 303.
  • [0183]
    [0183]FIG. 64 shows a sling assembly 320 comprising only a synthetic mesh material 322. Sutures 6 may be threaded through an eyelet of a needle to associate the assembly 320 with a needle. Optionally, a sheath may be added to the assembly 320, especially when the mesh 322 is elastic.
  • [0184]
    [0184]FIG. 65 illustrates a sling assembly 330 comprising a non-synthetic sling 332. Sutures 336 may be threaded through an eyelet of a needle to associate the assembly 330 with a needle. Optionally, suture anchors or pledgets may be utilized to avoid suture pull through.
  • [0185]
    [0185]FIG. 66 illustrates a sling assembly 340 comprising a sling mesh 342 and a sheath 344. In this embodiment, the ends of the sling mesh 342 may be attached to the ends of the sheath 340 by welding, suturing, or other suitable means. Sutures 346 may be tied about the ends of the sheath 344 to form a dilator-like structure for pushing tissue out of the way of the assembly 340 during implantation. The sutures 346 may be threaded through an eyelet of a needle to associate the assembly 340 with a needle. FIG. 66 also shows a tensioning suture, but this is optional and can be omitted.
  • [0186]
    [0186]FIG. 67 illustrates another sling assembly 350 comprising a synthetic mesh 352 and a sheath 354. Sutures 356 may be threaded through an eyelet of a needle to associate the sling 352 with a needle. Sutures 358 may be tied about the ends of the sheath 354 to form a dilator-like structure for pushing tissue out of the way of the assembly 350 during implantation. FIG. 67 also shows a tensioning suture T′, but this is optional and can be omitted.
  • [0187]
    Preferably, the handles of the surgical instruments shown in FIGS. 15-20B includes indicia indicating the proper side of the patient. For example, the indicia may be any suitable information conveying word, symbol or depiction. The indicia may simply be “right” or “left.” For those instruments designed for use on the right side of the patient, the indicia may include a drawing similar to FIG. 32. For the instruments designed for use on the left side of the patient, the indicia may include a drawing similar to FIG. 33.
  • [0188]
    The various embodiment of three dimensional needles described above preferably include a substantially straight spacer portion emerging from an end of the handle portion preferably along the handle axis. This helps afford convenient passage of the needle using an ergonomic wrist roll adopted by some surgeons. The three dimensional needles also include a structure that can be described as a variable spiral portion extending from the distal end of the straight spacer portion. As shown, the spiral portion is preferably variable as the angle of the spiral portion changes between the end of the extension portion and the distal end of the needle. The shape of the spiral portions help avoid over insertion of the needle into the body which helps avoid damage to the sensitive structures in this region of the body.
  • [0189]
    The variable spiral portions of the three dimensional needles have tissue clearance depth TCD of greater than about 0.5 inches and less than about 2.5 inches, more preferably the tissue clearance depth is between 0.75 inches and about 2.25 inches, more preferably it is between about 1.5 and 2 inches, and even more preferably it is about 2 inches. The tissue clearance depth TCD is the distance between the end of the extension portion and a point along an extension of the axis of the straight spacer portion which is defined by a line that is normal to the axis and that intersects the distal tip of the needle. The tissue clearance depth TCD helps space the distal tip of the needle from the distal end of the extension portion to reduce interference in needle passage by the distal end of the extension portion.
  • [0190]
    The variable spiral portions of the three dimensional needles have a maximum width MW that is preferably great enough to afford passage around the inferior pubic ramus and through the natural opening of the pubic bone, but small enough to avoid sensitive structure in this region of the body. Preferably, the maximum width MW is greater than about 1.25 inches and less than about 3 inches, more preferably, it is between about 2 and about 2.225 inches and more preferably, it is about 2.15 inches.
  • [0191]
    Referring to FIGS. 23, 24, 25, 25A and 26, there is shown a novel dilator 54S according to another aspect of the present invention. The dilator 54S includes a hole 90S for receiving a sling or a sheath or both in order to associate the dilator with a sheath.
  • [0192]
    Due to the more tortuous path associated with a transobturator route and the tighter radial passage, a shorter dilator is preferred to reduce tissue trauma and afford convenient, easy passage. Rotation of a helical needle can cause a substantially straight dilator to skid or plow through tissue instead of moving in a direction parallel to the longitudinal axis of the dilator. A shorter dilator will reduce tissue trauma associated with such plowing or skidding. Alternatively, a slightly curved or arcuate dilator may be used to reduce plowing or skidding.
  • [0193]
    The length L of a substantially straight dilator 54S is substantially short, preferably less than about 30 mm (1.2 inches) more preferably less than about 18 mm, 0.7 inches. The outermost diameter D of the dilator 54S is preferably less than about 6 mm 0.24 inches, more preferably less than about 5 mm, even more preferably, less than about 4 mm. The dilator 54S preferably has surfaces 51S that provide a smooth transition between the needle (e.g. 60L) and the sling assembly. The angle theta is preferably less than about 15 degrees and more preferably less than about 12 degrees.
  • [0194]
    In one embodiment of the present invention, one substantially straight dilator 54S may be used with either a left or a right side needle. Preferably, such a combination includes a distal region of the needle that is substantially straight. This length (e.g. L″ in FIG. 26A) is preferably short, preferably less than 0.9 inches, more preferably less than 0.8 inches, more preferably about 0.42 inches. In one embodiment, the length L′ in FIG. 25 may be 0.3 inches.
  • [0195]
    It is noted that the dilator is preferably capable of being “permanently affixed” to the needle. Preferably, the needle is attached to the dilator without a suture. FIG. 26A illustrates one example of a permanently affixed needle and sling assembly. By “permanent affixation”, it is meant that it would be very difficult to manually separate the dilator from the needle after they have become permanently affixed. After implantation of the sling, to separate the sling from the dilator/needle subassembly, the surgeon cuts an end of the sling assembly (e.g. a cut is made through the mesh and protective sleeve) to separate the mesh from the needle/dilator subassembly. The connection between the needle and dilator preferably affords quick and convenient attachment of the dilator to the needle to avoid wasting time in the midst of a surgical procedure. The attachment should also be secure to avoid separation of the needle and dilator while the combination is passed through tissue.
  • [0196]
    To accomplish the preferred attachment, the dilator 54S includes an internal stop surface 57S that is complementary with specially-shaped surfaces on a needle (e.g. 62R, FIG. 27). As best seen in FIG. 26A, the stop surface 57S is designed to engage complementary shoulder surface (e.g. 65R, FIG. 27) to achieve the desired convenient, but permanent affixation.
  • [0197]
    Also preferably, the needle is attached to the dilator without any screw-type connector. Preferably, the connection is a snap-fit, quick connection for secure, convenient use by the surgeon. Also preferably, the connection is a press on connection that does not require substantial rotation of elements (especially elements that are within the body) as such a connection is less likely to displace a needle or otherwise injure the patient.
  • [0198]
    Referring to FIG. 28, the dilators 54S may form a portion of a sling assembly that includes synthetic sling end portions 42A′, sheaths 44A′ covering at least some of the sling end portions 42A′ and a non-synthetic mid-portion 45′. A composite sling assembly may be assembled by the surgeon or provided preassembled using the teachings or components of published U.S. patent application Ser. Nos. 2002-0147382-A1 or 2002-0082619-A1, or U.S. patent application Ser. No. 10/335,119, filed Dec. 31, 2002.
  • [0199]
    In another aspect, the present invention comprises the ornamental design for a surgical instrument, as shown in FIGS. 39 through 45 and described in the Brief Description of the Drawings.
  • [0200]
    In another aspect, the present invention comprises the ornamental design for a surgical instrument, as shown in FIGS. 46 through 52 and described in the Brief Description of the Drawings.
  • [0201]
    The broken line showing in FIGS. 39-52 are for illustrative purposes only and form no part of the claimed design.
  • [0202]
    The above-described surgical instruments may be disposable or reusable. Optionally, portions of the surgical instrument may be reusable (sterilizable) and other components may be disposable.
  • [0203]
    Examples of Surgical Procedures
  • [0204]
    Several methods are contemplated herein. Although the methods of use as disclosed herein generally relate to female incontinence conditions and treatments/procedures, male incontinence conditions and treatments/procedures are also included within the scope of the present invention. Further, the term “urethra,” with respect to sling positioning, is used for brevity and reader convenience. It should be noted that the present invention is particularly suitable for placing a sling in a therapeutically effective position. The method may be utilized to support a variety of structures at different anatomical locations. Variations of these methods may occur due to individual surgeon's techniques or a patient's particular anatomy.
  • [0205]
    Referring to FIGS. 4 through 10, a preferred embodiment of surgical procedure is disclosed. The present invention utilizes an obturator passage of the needle, preferably in a direction from the anterior to the posterior side of the pubic bone. An obturator approach affords a sling procedure where previous scarring in the region of the retropubic space or other anatomical features would prevent or restrict a traditional pubovaginal sling procedure. An obturator approach is also likely to avoid bladder perforations a possible but rare complication with some prior art pubovaginal procedures. It may also be more convenient to conduct a concomitant repair (e.g. cystocele repair) with a sling inserted with a side approach as the sling is placed in a more horizontal position (e.g. see FIGS. 9 and 10) than the U-shaped sling procedures of the prior art.
  • [0206]
    Initially, the patient is placed under local, spinal or general anesthesia. A catheter 2 (e.g. Foley) may be inserted through the urethra 16. A small incision (e.g. a transverse incision) is made in the anterior vaginal wall 20 of a patient followed by a transurethral dissection. The amount of dissection may vary according to surgeon preference. Preferably, dissection is sufficient to allow the surgeon's finger to meet the end of the region 58 of the needle 60 just after it passes through the obturator fascia.
  • [0207]
    Two small stab incisions 400 are also made near the obturator fascia to afford needle entry. Notably, the precise location of the stab incisions 400 may vary according to surgeon preference. For example, some surgeons may place the incision adjacent the obturator opening of the pubic bone. Other surgeons may slightly offset the incision in order to use the bias provided by the patient's tissue to urge the tip of the needle in a direction toward the posterior surface of the pubic bone.
  • [0208]
    Referring to FIG. 4, the end of region 58 of needle 60 is shown just passing an incision 400 on the patient's right side. The surgeon's finger is initially placed in the vaginal incision sufficient to meet the end of region 58 of the needle 60 after it passes through the obturator fascia and the obturator foramen 3 (see FIG. 9). A path for the needle 60 through the obturator foramen 3 that is substantially free of vascular and nerve passages is selected. To select the path, the surgeon preferably initially identifies the anatomical structures of the pelvis such as the ischial tuberosity and obturator foramen 3 by palpation of the tissue.
  • [0209]
    If optional handle 64 is used, it may be adjusted relative to needle 60 according to surgeon preference and securely associated with the end 62 of the needle 60. FIG. 5 shows the end of region 58 of needle 60 just passing an incision 400 on the patient's left side.
  • [0210]
    Preferably, the surgeon seeks to use the posterior portion of the patient's pubic bone as an anatomical guide to controllably move the tip of region 58 of the needle toward the vaginal incision and to help avoid damaging structures. The surgeon exploits the tactile feel provided by the posterior portion of the pubic bone to controllably pass the tip of the needle 60. This approach is preferred as it helps keep the needle 60 away from the bladder and other vulnerable tissues.
  • [0211]
    [0211]FIG. 6 illustrates the needle of FIG. 5 as it emerges from a vaginal incision. The shape and size of needles 60 help provide precise passage of the needles 60 to the vaginal incision. The steps described above are repeated as needed for both sides of the urethra 16. FIG. 6 also illustrates one side of a sling assembly 46 prior to association with the needle 60.
  • [0212]
    [0212]FIG. 7 is a perspective view of one side of a sling system after it is associated with needle 60. The dilators 54 of the sling assembly 46 are preferably snapped irreversibly into place on the needles 60 for a secure connection. Next, if a synthetic sling assembly is used, the plastic sheath 44 is oriented so that an optional center orientation indicia (e.g. a blue mark) is facing away from the surgical field, toward the surgeon.
  • [0213]
    After the dilators 54 are attached to the needles 60, the sling assembly 46 is properly oriented so that the sling assembly 46 is not twisted when attached to the dilators 54. After the dilators 54 and sling assembly 46 are properly positioned, dilators 54 and sling assembly 46 are pulled through the tissues of the patient
  • [0214]
    Referring to FIG. 8, once the dilators 54 are securely attached, the needles are pulled through the incisions 400, taking care to avoid contact with sensitive tissue. The sling is then clamped with surgical clamps (not shown). During this portion of the process, the attached dilators 54 and sling assembly 46 are atraumatically pulled through the needle paths, advancing the sling assembly 46 adjacent to and beneath the urethra 16 or target site. A portion of each end of the sling assembly 46 extending beyond the incisions 400 is clamped and then cut to release the needles 60 and attached dilators 54.
  • [0215]
    The sling is placed in a therapeutically effective position. FIGS. 9 and 10 show one example of a therapeutically effective position. Other positions are contemplated herein. The precise anatomical position will depend upon a variety of factors including the type and degree of anatomical damage or insufficiency, location of significant scar tissue, whether the sling procedure is combined with other procedures and other surgeon decisions. Typically, the sling is placed midurethra, without tension, but in position to support the midurethra. Alternatively, the sling could be placed to support the bladder neck and/or UV junction.
  • [0216]
    Once the sling assembly 46 is carefully positioned under the midurethra or target site to provide sufficient support to the target site, the overlapping portion of the sheath 44 located near the center of the sling assembly 46 and an optional tensioning member (i.e. tensioning filament) may then be used to center and properly position the sling assembly 46 under the midurethra. The sheath 44 is then removed.
  • [0217]
    Sling tension may be tightened by placing a device, such as a clamp, across one or both ends of the sling 42. Generally, the surgeon grasps the mesh and tensioning filament together adjacent the incision 400 and pulls to increase the degree of tightness of the mesh.
  • [0218]
    After the dilators 54 are trimmed off, the plastic sheath 44 is removed from the sling mesh 42 by pulling on both sides of the sheath 44, preferably one at a time. Optionally, to avoid overtightening the sling mesh 42 while removing the sheath 44, a forceps or other blunt instrument may be placed between the sling and the urethra.
  • [0219]
    [0219]FIGS. 9 and 10 illustrate one embodiment of the final placement of the sling 42 relative to anatomical structures such as the pubic bone, urethra and vagina. The sling is flatter than the U-shaped slings of the prior art which extend to the rectus fascia of the patient's abdomen.
  • [0220]
    In another embodiment of the invention, shown with reference to FIG. 11, a method includes the steps of providing a surgical kit comprising at least one guide needle 60 constructed for an obturator approach, and at least one sling transport needle 604 with a sharp tip, a sling 610 attached to the sling transport needle 604, and a dilator 54 having tip receiving surfaces for receiving the sharp tip of the sling transport needle 604. The needle 60 has a relatively small diameter (e.g. less than 4 mm). The method includes the steps of creating at least one vaginal incision, creating two obturator stab incisions, and initially passing a guide needle 60 through the obturator incision and then through the vaginal incision. The dilator 54 is then attached or associated with the needle 60.
  • [0221]
    Needles 604 are initially guided through a vaginal incision and toward one of the obturator incisions 400. Guiding the sharp tip of the large sling transport needle 604 in this fashion is believed to help avoid contact between the sharp tip of needle 604 and sensitive structures. Optionally the adapter with receiving surfaces may be integrally formed in the needle 604 to avoid the need to separately attach the adapter to the needle 604.
  • [0222]
    [0222]FIG. 4A shows an alternative step according to an aspect of a method according to the present invention. This illustrates a method wherein the needle 60 of FIG. 1 is initially inserted through a vaginal incision and then emerges from a skin incision. In this embodiment, the sling assembly may then be attached to the end of the needle previously occupied by a removable and repositionable handle 64. The handle 64 may then optionally be placed on the other end of the needle 60 to assist the surgeon in passing the sling assembly and needle through the body. This is shown by the arrow in FIG. 4A adjacent the dotted line showing of the handle 64.
  • [0223]
    The method preferably includes the step of removing the handle 64 and attaching an end of the sling assembly to the region of the needle previously occupied by the handle 64. The needle tip and attached sling assembly are then passed completely through the body, in substantially the same direction as the initial insertion, to place one side of the sling assembly. As a result, it can be seen that the needle 60 is a universal needle (i.e. one that can be utilized for either an “outside-in” surgical approach or an “inside-out” approach).
  • [0224]
    Referring now to FIGS. 31-38, there is shown another embodiment of method according to the present invention. This embodiment is believed to be suitable for patients under local, regional or general anesthesia. This embodiment utilizes needles specially shaped for use on a predetermined side (e.g. right or left) of the patient.
  • [0225]
    A small incision may be made in the anterior vaginal wall followed by pariurethral dissection. Two small stab incisions are also made above the obturator foramen for instrument passage.
  • [0226]
    The patient is preferably placed in a modified lithotomy position with hips flexed, legs elevated. The bladder is emptied and a weighted vaginal retractor may be used.
  • [0227]
    The surgeon palpates the inferior portion of the ischiopubic ramus, palpates the edge of the bone and notes where the ischiopubic branch gets wider and the obturator membrane is tactily sensed. Just below this location and lateral to the bone is a preferred mark for the skin incisions. The surgeon preferably confirms that both marks lie in a straight line approximately at the level of the clitoris.
  • [0228]
    In the anterior wall of the vagina, the surgeon may draw a vertical mark approximately 0.5 cm below the meatus. The incision may be approximately 2 cm in length. An Allis forceps may be placed on the incision margin to expose the incision.
  • [0229]
    The surgeon incises the vaginal wall and extend the dissection laterally (pariurethral) with, for example, a Metzenbaum scissors. The surgeon then may dissect the pariurethral attachment to the vagina. The surgeon may then insert the tip of a blunt instrument (e.g. the Metzenbaum scissors laterally), spread and advance the scissors until the tip of the scissors touches the inferior portion of the bone (about 1-1.5 cm). This may be accomplished bilaterally. The vaginal dissection is preferably large enough for a finger tip to enter in both directions.
  • [0230]
    The instrument is then passed through the obturator foramen. The surgeon preferably palpates the interior portion of the ischiopubic ramus, palpates the edge of the bone and preferably moves his or her finger cephalad until muscle firmness is felt. Just below this location and lateral to the bone may be the mark for the skin incisions. The surgeon may confirm that both marks lie approximately in a straight line at the level of the clitoris.
  • [0231]
    The surgeon may then insert the index finger into the vaginal dissection and probe to the ipsilateral outer obturator foramen mark to confirm needle path. The surgeon makes a small vertical skin incision on the same side over the skin mark denoting the foramen. If patient side specific instruments are used (e.g. those shown in FIGS. 15-22), the instrument designated for the patients left side 60L may be removed from the package. The surgeon points the instrument tip perpendicular to the skin and proceeds to the level of the obturator fascia.
  • [0232]
    With a finger in vaginal incision, the surgeon moves the finger laterally to meet the needle tip (see FIG. 35). When passing the needle 60L on the patient's left side, the surgeon preferably keeps his or her right hand on the needle handle and left index finger in the vaginal incision. The surgeon's left thumb may optionally be on the outside curve of the needle 60L to control the needle movement. The surgeon's left thumb preferably pushes the needle through the muscles and obturator fascia. The needle tip preferably penetrates until resistance of the tissue stops—about 0.5 cm.
  • [0233]
    The surgeon then preferably immediately locates the ischial pubic ramus with the needle tip 62L and rotates the needle handle 64L (see FIG. 33) to allow the needle to follow the posterior ischial pubic ramus surface. The index finger tip should palpate the needle tip. If not, the surgeon should move the needle to meet the finger tip. If the needle tip cannot be located, then the needle should be withdrawn just behind the ischial pubic ramus and advanced again.
  • [0234]
    Using the index finger, the surgeon preferably guides the instrument tip medially towards the vaginal incision until the instrument tip extends through the incision (see FIG. 36).
  • [0235]
    The above steps are repeated on the patient's right side. See FIGS. 32 and 34. Cystoscopy may not be required but can be done at the surgeon's discretion.
  • [0236]
    The surgeon then attaches the dilating connectors (that are pre-attached to the sling mesh) to the regions of the instruments 60L and 60R that emerge from the vaginal incision. One dilating connector 54S should be attached to each of the instruments 60L and 60R on the regions protruding from the vagina. If optional colored markings or indices are used on the sling assembly, the surgeon orients these markings on the sheath facing outward, away from the urethra 16. The surgeon may use the markings to help ensure that the sling mesh lies flat and that the mesh is not twisted prior to attaching the second dilator 54S as the dilators cannot be removed once they are snapped into place.
  • [0237]
    The surgeon then pulls the assembly through the lateral incision. This is shown for the left side of the patient's body in FIG. 37. Next the surgeon cuts the sling mesh just below the level of the connector and discards the needle and dilator. In FIG. 38, this has been accomplished for the portion of the system on the right side of the patient's body.
  • [0238]
    The surgeon preferably keeps the centering marks on the plastic sheath in the midline. This is repeated on the contralateral side.
  • [0239]
    If vaginal retraction has been used, it should be removed to adjust the tension of the sling. The sling may be finely tensioned by placing a blunt instrument (e.g. a Metzenbaum scissors or small instrument) between the sling and urethra.
  • [0240]
    The surgeon removes the plastic protective sheaths 44A and discards them.
  • [0241]
    Under spinal or regional anesthesia, the position of the sling can be improved by the cough test after filling up the bladder, at the discretion of the surgeon.
  • [0242]
    To loosen the mesh, the surgeon place an instrument (e.g. Metzenbaum clamp) between the sling mesh and the urethra. The surgeon ensures that both the mesh and the tensioning suture are located beneath the clamp. The clamp may be used to pull down and loosen the sling mesh as desired.
  • [0243]
    To tighten the sling mesh, the surgeon places a clamp (e.g. hemostat) across the sling mesh at the lateral incisions 400. The surgeon ensures that both the tensioning suture and the complete width of the sling are captured within the clamp. The sling mesh may be rolled around the clamp to improve the grip. The surgeon pulls up to tighten the sling mesh as desired. If needed, this can be repeated on the contralateral side.
  • [0244]
    To complete the procedure, the surgeon trims the sling mesh at the level of the subcutaneous tissue. A multi-layer closure of the vaginal incision and the skin incisions may then be completed.
  • [0245]
    All patents, patent applications, and publications cited herein are hereby incorporated by reference in their entirety as if individually incorporated.
  • [0246]
    Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2738790 *12 Aug 195420 Mar 1956George P Pilling & Son CompanySuturing instrument
US3124136 *3 Jan 196110 Mar 1964 Method of repairing body tissue
US3182662 *25 Jul 196211 May 1965Shirodkar Vithal NPlastic prosthesis useful in gynaecological surgery
US3311110 *15 Jul 196428 Mar 1967American Cyanamid CoFlexible composite suture having a tandem linkage
US3384073 *21 Apr 196421 May 1968Ethicon IncSurgical device for correction of urinary incontinence
US3580313 *7 Jan 196925 May 1971Mcknight Charles ASurgical instrument
US3789828 *1 Sep 19725 Feb 1974Heyer Schulte CorpUrethral prosthesis
US3858783 *20 Nov 19727 Jan 1975Jurasova Nina VasilievnaSurgical instrument for stitching up tissues with lengths of suture wire
US4019499 *22 Apr 197626 Apr 1977Heyer-Schulte CorporationCompression implant for urinary incontinence
US4037603 *13 May 197526 Jul 1977Wendorff Erwin RMetallic surgical suture
US4246660 *26 Dec 197827 Jan 1981Queen's University At KingstonArtificial ligament
US4441497 *21 Oct 198210 Apr 1984Paudler Franklin TUniversal suture passer
US4509516 *24 Feb 19839 Apr 1985Stryker CorporationLigament tunneling instrument
US4857041 *7 May 198715 Aug 1989National Research Development CorporationUrinary incontinence prostheses
US4865031 *3 Oct 198812 Sep 1989Keeffe Paul J OFabric and method of use for treatment of scars
US4920986 *13 Oct 19871 May 1990Zedlani Pty. LimitedUrinary incontinence device
US5085661 *29 Oct 19904 Feb 1992Gerald MossSurgical fastener implantation device
US5112344 *4 Oct 198912 May 1992Petros Peter ESurgical instrument and method of utilization of such
US5123428 *10 Oct 199123 Jun 1992Schwarz Gerald RLaparoscopically implanting bladder control apparatus
US5188636 *7 May 199223 Feb 1993Ethicon, Inc.Purse string suture instrument
US5207694 *18 Jun 19924 May 1993Surgical Invent AbMethod for performing a surgical occlusion, and kit and applicator for carrying out the method
US5209756 *5 Nov 199011 May 1993Bahaa Botros SeedhomLigament fixation staple
US5281237 *25 Sep 199225 Jan 1994Gimpelson Richard JSurgical stitching device and method of use
US5328077 *19 Nov 199212 Jul 1994Lou Ek SengMethod and apparatus for treating female urinary incontinence
US5336239 *15 Jan 19939 Aug 1994Gimpelson Richard JSurgical needle
US5337736 *30 Sep 199216 Aug 1994Reddy Pratap KMethod of using a laparoscopic retractor
US5383904 *13 Oct 199224 Jan 1995United States Surgical CorporationStiffened surgical device
US5386836 *9 Jul 19937 Feb 1995Zedlani Pty LimitedUrinary incontinence device
US5403328 *3 Feb 19934 Apr 1995United States Surgical CorporationSurgical apparatus and method for suturing body tissue
US5413598 *15 Jul 19949 May 1995C. R. Bard, Inc.Vascular graft
US5439467 *17 Jun 19938 Aug 1995Vesica Medical, Inc.Suture passer
US5520700 *10 Nov 199328 May 1996Technion Research & Development Foundation, Ltd.Stapler device particularly useful in medical suturing
US5520703 *7 Jun 199328 May 1996Essig; Mitchell N.Laparoscopic deschamp and associated suturing technique
US5544664 *16 May 199413 Aug 1996Benderev; Theodore V.Method of advancing a suture through tissue
US5591163 *14 Jun 19957 Jan 1997Incont, Inc.Apparatus and method for laparoscopic urethropexy
US5611515 *5 Apr 199318 Mar 1997Boston Scientic CorporationBladder neck suspension procedure
US5628756 *29 Jul 199613 May 1997Smith & Nephew Richards Inc.Knotted cable attachment apparatus formed of braided polymeric fibers
US5633286 *11 Aug 199427 May 1997Applied Elastomerics, Inc.Gelatinous elastomer articles
US5669935 *28 Jul 199523 Sep 1997Ethicon, Inc.One-way suture retaining device for braided sutures
US5807403 *26 Mar 199615 Sep 1998Technion Research And Development Foundation, Ltd.Medical anchor device with suture thread and method for implantation into bone
US5860425 *26 Jan 199619 Jan 1999Boston Scientific Technology, Inc.Bladder neck suspension procedure
US5899909 *25 Feb 19974 May 1999Medscand Medical AbSurgical instrument for treating female urinary incontinence
US5919232 *23 May 19956 Jul 1999CogentProsthetic fabric
US5934283 *15 Apr 199710 Aug 1999Uroplasty, Inc.Pubovaginal sling device
US5935122 *1 Aug 199710 Aug 1999Endovascular Technologies, Inc.Dual valve, flexible expandable sheath and method
US5944732 *27 Aug 199731 Aug 1999Medical Components, Inc.Subcutaneous tunnelling device and methods of forming a subcutaneous tunnel
US6010447 *31 Jul 19984 Jan 2000Kardjian; Paul M.Bladder sling
US6030393 *15 Sep 199829 Feb 2000Corlew; Earvin L.Needle and procedure for relieving urinary incontinence
US6031148 *2 Apr 199329 Feb 2000W. L. Gore & Associates, Inc.Implantable bioabsorbable article
US6042534 *13 Feb 199828 Mar 2000Scimed Life Systems, Inc.Stabilization sling for use in minimally invasive pelvic surgery
US6042536 *13 Aug 199828 Mar 2000Contimed, Inc.Bladder sling
US6048351 *10 Apr 199811 Apr 2000Scimed Life Systems, Inc.Transvaginal suturing system
US6050937 *21 Sep 199818 Apr 2000Benderev; Theodore V.Surgical tension/pressure monitor
US6053935 *8 Nov 199625 Apr 2000Boston Scientific CorporationTransvaginal anchor implantation device
US6068591 *17 Feb 199830 May 2000Bruckner; Norman I.Pubo-urethral support harness apparatus for percutaneous treatment of female stress urinary incontinence
US6071290 *24 Sep 19966 Jun 2000Compton; Jeffrey SpencerSurgical clip set
US6099538 *2 Feb 19998 Aug 2000T.A.G. Medical ProductsSet of surgical tools and surgical method for connecting soft bone parts to one another or to connective tissue
US6106545 *16 Apr 199822 Aug 2000Axya Medical, Inc.Suture tensioning and fixation device
US6110101 *23 Mar 199929 Aug 2000Conticare Medical, Inc.Bladder sling
US6168611 *8 Sep 19992 Jan 2001Syed RizviSuturing needle assemblies and methods of use thereof
US6221005 *7 Sep 199924 Apr 2001Norman I. BrucknerPubo-urethral support harness apparatus for percutaneous treatment of female stress urinary incontinence with urethal hypemobility
US6273852 *9 Mar 200014 Aug 2001Ethicon, Inc.Surgical instrument and method for treating female urinary incontinence
US6334446 *7 Apr 19991 Jan 2002American Medical Systems, Inc.Medical sling procedures and anchor insertion methods and devices
US6352553 *18 Jul 19975 Mar 2002Gore Enterprise Holdings, Inc.Stent-graft deployment apparatus and method
US6382214 *22 Apr 19997 May 2002American Medical Systems, Inc.Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele
US6406423 *21 Jan 200018 Jun 2002Sofradim ProductionMethod for surgical treatment of urinary incontinence and device for carrying out said method
US6406480 *5 Oct 199918 Jun 2002American Med SystBone anchor inserter with retractable shield
US6502578 *27 Dec 20007 Jan 2003Ams Research CorporationMethod and apparatus for correction for gynecological pathologies including treatment of female cystocele
US6530943 *20 Nov 200011 Mar 2003Ethicon, GmbhSurgical needle for implanting a tape
US6582443 *27 Dec 200024 Jun 2003Ams Research CorporationApparatus and methods for enhancing the functional longevity and for facilitating the implantation of medical devices
US20010000533 *20 Dec 200026 Apr 2001Kovac S. RobertTransvaginal bone anchor implantation device
US20020022841 *11 Oct 200121 Feb 2002Kovac S. RobertSling system for treating incontinence
US20020028980 *24 Aug 20017 Mar 2002American Medical SystemsImplantable article and method
US20020055748 *12 Nov 20019 May 2002Gellman Barry N.Devices for minimally invasive pelvic surgery
US20020058959 *14 Nov 200116 May 2002Gellman Barry N.Treating urinary incontinence
US20020068948 *23 Apr 20016 Jun 2002Johan StormbyAiming device for surgical instrument and method for use for treating female urinary incontinence
US20020072694 *24 Aug 200113 Jun 2002Snitkin Eva S.Coated sling material
US20020077526 *4 Jun 200120 Jun 2002Kammerer Gene W.Surgical instrument and method for treating female urinary incontinence
US20020078964 *27 Dec 200027 Jun 2002American Medical Systems, Inc.Pelvic surgery drape
US20020091298 *19 Sep 200111 Jul 2002Susanne LandgrebeSystem with a surgical needle and a handle
US20020091373 *26 Sep 200111 Jul 2002Yitzhak BergerSurgical apparatus and methods for delivery of a sling in the treatment of female urinary incontinence
US20020099258 *27 Jul 200125 Jul 2002Staskin David R.Sling delivery system and method of use
US20020099259 *27 Jul 200125 Jul 2002Anderson Kimberly A.Surgical instrument and method
US20020099260 *5 Mar 200225 Jul 2002Patrice SuslianMethod for treating urinary incontinence in women and implantable device intended to correct urinary incontinence
US20020107430 *27 Jul 20018 Aug 2002Neisz Johann J.Implantable article and method
US20020107525 *2 Feb 20018 Aug 2002American Medical Systems, Inc.Powered bone screw device
US20020115906 *23 Oct 200122 Aug 2002Ethicon, Inc.Apparatus and method for the measurement and assessment of sling-tension for treatment of female urinary incontinence
US20030004395 *22 May 20022 Jan 2003Sofradim ProductionSuburethral support assembly in treatment of female urinary stress incontinence
US20030009181 *7 Mar 20029 Jan 2003Gellman Barry N.System for implanting an implant and method thereof
US20030023136 *23 Sep 200230 Jan 2003Shlomo RazMethods and apparatus for correction of urinary and gynecological pathologies, including treatment of male incontinence, and female cystocele
US20030023137 *27 Jul 200130 Jan 2003Gellman Barry N.Medical slings
US20030023138 *26 Sep 200230 Jan 2003Luscombe Brian H.Surgical instrument and method for treating female urinary incontinence
US20030036676 *11 Oct 200220 Feb 2003Sofradim ProductionPercutaneous device and method for treating urinary stress incontinence in women using a sub-urethral tape
US20030045774 *25 Oct 20026 Mar 2003Staskin David R.Sling delivery system and method of use
US20030050530 *25 Oct 200213 Mar 2003Neisz Johann J.Surgical articles and methods
US20030065346 *21 Oct 20023 Apr 2003Evens Carl J.Drug releasing anastomosis devices and methods for treating anastomotic sites
US20030065402 *30 Oct 20013 Apr 2003Ameican Medical SystemsImplantable article
US20030130670 *31 Dec 200210 Jul 2003Anderson Kimberly A.Pelvic floor implant system and method of assembly
US20030149440 *31 Oct 20027 Aug 2003Ethicon, Inc.Surgical instrument and method for treating female urinary incontinence
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US73712458 Jun 200513 May 2008C R Bard, IncTransobturator introducer system for sling suspension system
US739332028 Apr 20061 Jul 2008Ams Research CorporationPelvic floor health articles and procedures
US757227427 May 200411 Aug 2009Cardiva Medical, Inc.Self-tensioning vascular occlusion device and method for its use
US7608081 *18 Aug 200527 Oct 2009Custom Spine, Inc.Rod reducer
US761145427 May 20043 Nov 2009Universite De LiegeSurgical procedure for the treatment of female urinary incontinence: tension-free inside-out transobturator urethral suspension
US77131874 Oct 200411 May 2010Boston Scientific Scimed, Inc.Systems and methods for delivering a medical implant to an anatomical location in a patient
US772252726 Apr 200525 May 2010Ams Research CorporationSurgical implants and related methods
US776303424 Jan 200627 Jul 2010Medtronic, Inc.Transobturator lead implantation for pelvic floor stimulation
US782432629 Feb 20082 Nov 2010Boston Scientific Scimed, Inc.Bioabsorbable casing for surgical sling assembly
US797569823 May 200512 Jul 2011Coloplast A/SImplant for treatment of vaginal and/or uterine prolapse
US798517317 Mar 200626 Jul 2011Ethicon, Inc.Method and apparatus for treating pelvic organ prolapses in female patients
US7993366 *25 Oct 20049 Aug 2011Cardiva Medical, Inc.Self-tensioning vascular occlusion device and method for its use
US800743016 Jul 201030 Aug 2011Coloplast A/SApparatus and method for treating female urinary incontinence
US80167416 Apr 200613 Sep 2011Boston Scientific Scimed, Inc.Systems, devices, and methods for sub-urethral support
US803398314 Aug 200311 Oct 2011Boston Scientific Scimed, Inc.Medical implant
US804320513 Jul 200525 Oct 2011Boston Scientific Scimed, Inc.Snap fit sling anchor system
US80479834 Apr 20111 Nov 2011Coloplast A/SSurgical system for supporting pelvic anatomy
US80970071 Aug 200317 Jan 2012C. R. Bard, Inc.Self-anchoring sling and introducer system
US810986628 May 20097 Feb 2012Ams Research CorporationMethod and apparatus for prolapse repair
US811872714 Jun 201121 Feb 2012Coloplast A/SMethod for supporting pelvic anatomy
US811872821 Jun 201121 Feb 2012Coloplast A/SMethod for implanting an adjustable surgical implant for treating urinary incontinence
US81236713 Aug 200628 Feb 2012C.R. Bard, Inc.Pelvic implant systems and methods
US812367321 Jun 201128 Feb 2012Coloplast A/SAdjustable surgical implant for treating urinary incontinence
US812855414 Jun 20116 Mar 2012Coloplast A/SSystem for introducing a pelvic implant
US81423455 May 200527 Mar 2012Boston Scientific Scimed, Inc.Systems and methods employing a push tube for delivering a urethral sling
US81628181 Jun 201124 Apr 2012Coloplast A/SAdjustable surgical implant for pelvic anatomy
US816778528 Feb 20081 May 2012Coloplast A/SUrethral support system
US816778610 May 20101 May 2012Boston Scientific Scimed, Inc.Systems and methods for delivering a medical implant to an anatomical location in a patient
US818241217 Jun 201122 May 2012Coloplast A/SPelvic implant with fibrous anchor
US818241317 Jun 201122 May 2012Coloplast A/SMethod for fibrous anchoring of a pelvic support
US820628012 Nov 200826 Jun 2012C. R. Bard, Inc.Adjustable tissue support member
US821531028 Apr 201110 Jul 2012Coloplast A/SImplant for treatment of vaginal and/or uterine prolapse
US82730111 Jun 201125 Sep 2012Coloplast A/SAdjustable surgical implant and method for treating urinary incontinence
US827742630 Sep 20092 Oct 2012Wilcox Heather JMale urinary incontinence device
US83231796 Apr 20094 Dec 2012Boston Scientific Scimed, Inc.Systems and methods relating to associating a medical implant with a delivery device
US838851426 Oct 20075 Mar 2013Ams Research CorporationSurgical articles and methods for treating pelvic conditions
US84398208 Jun 200514 May 2013Boston Scientific Scimed, Inc.Systems and methods for sling delivery and placement
US84399446 Jul 200914 May 2013Cardiva Medical, Inc.Self-tensioning vascular occlusion device and method for its use
US84494501 Jun 201128 May 2013Coloplast A/SPass through introducer and sling
US84544921 Jun 20114 Jun 2013Coloplast A/SAbsorbable anchor and method for mounting mesh to tissue
US846016922 Jun 200711 Jun 2013Ams Research CorporationAdjustable tension incontinence sling assemblies
US846017014 Jun 201111 Jun 2013Ethicon, Inc.Method and apparatus for treating pelvic organ prolapses in female patients
US846987526 Aug 200925 Jun 2013Coloplast A/SMethod and device for treating urinary incontinence
US846987727 Jan 201225 Jun 2013Coloplast A/SSystem for introducing a pelvic implant
US848055614 Jun 20119 Jul 2013Ethicon, Inc.Method and apparatus for treating pelvic organ prolapses in female patients
US848055912 Sep 20079 Jul 2013C. R. Bard, Inc.Urethral support system
US8500624 *25 Oct 20046 Aug 2013Boston Scientific Scimed, Inc.Systems and methods for sling delivery and placement
US85122231 Jun 201120 Aug 2013Coloplast A/SPelvic implant with selective locking anchor
US853521725 Jul 200617 Sep 2013Ams Research CorporationMethods and systems for treatment of prolapse
US855679731 Jul 200815 Oct 2013Ethicon, Inc.Magnetic implants for treating obstructive sleep apnea and methods therefor
US856161624 Oct 200822 Oct 2013Ethicon, Inc.Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea
US856161730 Oct 200822 Oct 2013Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US85741481 Jun 20115 Nov 2013Coloplast A/SSystem for introducing soft tissue anchors
US857414915 Jun 20125 Nov 2013C. R. Bard, Inc.Adjustable tissue support member
US859717325 Jul 20083 Dec 2013Ams Research CorporationPelvic floor treatments and related tools and implants
US860864127 Jun 200817 Dec 2013Ams Research CorporationPelvic floor health articles and procedures
US862846322 Jun 200714 Jan 2014Ams Research CorporationAdjustable tension incontinence sling assemblies
US862846514 Jun 200514 Jan 2014Boston Scientific Scimed, Inc.Systems, methods and devices relating to implantable supportive slings
US863248815 Dec 200921 Jan 2014Ethicon, Inc.Fluid filled implants for treating medical conditions
US864159712 Aug 20094 Feb 2014Oniversite de LičgeSurgical procedure for the treatment of female urinary incontinece: tension-free inside-out transobturator urethral suspension
US866863523 Feb 201211 Mar 2014Coloplast A/SPelvic implant with suspending system
US867800830 Jul 200825 Mar 2014Ethicon, IncMethods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US870888519 Sep 200829 Apr 2014Ams Research CorporationPelvic floor treatments and related tools and implants
US87094716 Oct 200829 Apr 2014Coloplast A/SMedicament delivery device and a method of medicament delivery
US872796331 Jul 200920 May 2014Ams Research CorporationMethods and implants for treating urinary incontinence
US87778374 Feb 201315 Jul 2014Ams Research CorporationSurgical articles and methods for treating pelvic
US87832581 Dec 200822 Jul 2014Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US878429525 May 201122 Jul 2014Ams Research CorporationSling assembly with secure and convenient attachment
US879024026 Mar 201229 Jul 2014Boston Scientific Scimed, Inc.Systems and methods employing a push tube for delivering a urethral sling
US880056713 Oct 200912 Aug 2014Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US880159614 Jun 201112 Aug 2014Coloplast A/SSling with support and suspending members formed from same polymer
US880816228 Mar 201219 Aug 2014Ams Research CorporationImplants, tools, and methods for treatment of pelvic conditions
US88137547 Jan 201326 Aug 2014Ethicon, Inc.Magnetic implants and methods for treating an oropharyngeal condition
US88213691 Jun 20112 Sep 2014Colorplast A/SMethod for soft tissue anchoring with introducer
US882137014 Aug 20132 Sep 2014Coloplast A/SDevice, system and methods for introducing soft tissue anchors
US883435015 Jun 200716 Sep 2014Ams Research CorporationSurgical implants, tools, and methods for treating pelvic conditions
US88455126 Jan 201230 Sep 2014C. R. Bard, Inc.Sling anchor system
US885207512 Jun 20117 Oct 2014Coloplast A/SPelvic implant systems and methods with expandable anchors
US886465020 Jun 200621 Oct 2014Ams Research CorporationMethods and apparatus for securing a urethral sling to a pubic bone
US888867812 Jun 201118 Nov 2014Coloplast A/SPelvic implant with suspending system
US890503328 Sep 20119 Dec 2014Ethicon, Inc.Modular tissue securement systems
US89113471 Jun 201116 Dec 2014Coloplast A/SSystem and method for treating urinary incontinence
US89152528 Mar 201323 Dec 2014Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US892030415 Dec 201130 Dec 2014Coloplast A/SMethod and device for treating urinary incontinence
US89203081 Jun 201130 Dec 2014Coloplast A/SSurgical implant with anchor introducer channel
US893220214 Jun 201113 Jan 2015Coloplast A/SIncontinence implant with soft tissue anchors and length not allowing abdominal wall penetration
US894499027 Oct 20093 Feb 2015Ams Research CorporationSurgical needle and anchor system with retractable features
US895118518 May 200910 Feb 2015Ams Research CorporationSurgical articles and methods for treating pelvic conditions
US895416225 Apr 200710 Feb 2015Medtronic, Inc.Medical device implantation
US897358230 Nov 201110 Mar 2015Ethicon, Inc.Tongue suspension device and method
US897973228 Sep 201117 Mar 2015Ams Research CorporationMethod and apparatus for treatment of vaginal anterior repairs
US900522213 Jan 201214 Apr 2015Coloplast A/SSelf-anchoring sling and introducer system
US901724322 Dec 201128 Apr 2015Ams Research CorporationMinimally invasive implant and method
US90229207 Sep 20115 May 2015Boston Scientific Scimed, Inc.Systems, devices, and methods for sub-urethral support
US902292227 Mar 20145 May 2015Ams Research CorporationMethods and implants for treating urinary incontinence
US905016427 Apr 20129 Jun 2015Boston Scientific Scimed, Inc.Systems and methods for delivering a medical implant to an anatomical location in a patient
US906083820 Apr 201223 Jun 2015Coloplast A/STissue supported implantable device
US906083913 Sep 201323 Jun 2015Ams Research CorporationMethods and systems for treatment of prolapse
US908466421 May 200721 Jul 2015Ams Research CorporationMethod and articles for treatment of stress urinary incontinence
US908939328 Mar 201228 Jul 2015Ams Research CorporationImplants, tools, and methods for treatment of pelvic conditions
US908939410 Jan 201428 Jul 2015Coloplast A/SPelvic implant with suspending system
US908939614 Aug 201328 Jul 2015Coloplast A/SUrinary incontinence treatment and devices
US910765923 Sep 201118 Aug 2015Boston Scientific Scimed, Inc.Snap fit sling anchor system and related methods
US91139913 May 201225 Aug 2015Boston Scientific Scimed, Inc.Anchors for bodily implants and methods for anchoring bodily implants into a patient's body
US91139923 Sep 201425 Aug 2015Coloplast A/SApparatus and method for treating urinary incontinence
US91257179 Sep 20118 Sep 2015Ams Research CorporationImplant tension adjustment system and method
US914442616 Feb 200729 Sep 2015Ams Research CorporationSurgical articles and methods for treating pelvic conditions
US91445114 Mar 201329 Sep 2015Ethicon, Inc.Methods and devices for treatment of obstructive sleep apnea
US916185524 Oct 201120 Oct 2015Ethicon, Inc.Tissue supporting device and method
US917367821 Jun 20103 Nov 2015Medtronic, Inc.Transobturator lead implantation for pelvic floor stimulation
US91737661 Jun 20123 Nov 2015Ethicon, Inc.Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
US917999218 Aug 201410 Nov 2015Ams Research CorporationImplants, tools, and methods for treatment of pelvic conditions
US918648910 Mar 201417 Nov 2015Coloplast A/SImplantable delivery device system for delivery of a medicament to a bladder
US91924588 Feb 201324 Nov 2015Ams Research CorporationImplants, tools, and methods for treatments of pelvic conditions
US922680910 Feb 20105 Jan 2016Ams Research CorporationSurgical articles and methods for treating urinary incontinence
US922681025 Jul 20145 Jan 2016Boston Scientific Scimed, Inc.Systems and methods employing a push tube for delivering a urethral sling
US927793611 Jan 20108 Mar 2016Kenneth FinkelsteinSurgical instrument having an integrated local anesthetic delivery system
US928306418 Jun 201515 Mar 2016Ams Research CorporationMethods and systems for treatment of prolapse
US932688629 Oct 20093 May 2016Ethicon, Inc.Fluid filled implants for treating obstructive sleep apnea
US933306528 Apr 201410 May 2016Astora Women's Health, LlcPelvic floor treatments and related tools and implants
US934547330 Dec 201024 May 2016Astora Women's Health, LlcImplantable sling systems and methods
US934586714 Oct 201524 May 2016Coloplast A/SDevice implantable in tissue of a prostate gland or a bladder
US935172329 Jun 201231 May 2016Astora Women's Health, LlcImplants, tools, and methods for treatments of pelvic conditions
US936430830 Dec 201014 Jun 2016Astora Women's Health, LlcImplant systems with tensioning feedback
US937530213 Jan 201428 Jun 2016Astora Women's Health, LlcAdjustable tension incontinence sling assemblies
US938107623 Feb 20115 Jul 2016Boston Scientific Scimed, Inc.Surgical articles and methods
US939309131 Dec 201019 Jul 2016Astora Women's Health, LlcSuture-less tissue fixation for implantable device
US939913025 Apr 200726 Jul 2016Medtronic, Inc.Cannula configured to deliver test stimulation
US941490323 Jul 201216 Aug 2016Astora Women's Health, LlcPelvic implant system and method
US944588116 Dec 201120 Sep 2016Boston Scientific Scimed, Inc.Surgical articles and methods
US94921913 Aug 201215 Nov 2016Astora Women's Health, LlcTools and methods for treatment of pelvic conditions
US949225930 Mar 201215 Nov 2016Astora Women's Health, LlcExpandable implant system
US9504467 *23 Dec 201029 Nov 2016Boston Scientific Scimed, Inc.Less traumatic method of delivery of mesh-based devices into human body
US95328619 May 20143 Jan 2017Coloplast A/SSelf-anchoring sling and introducer system
US95328629 May 20143 Jan 2017Coloplast A/SSelf-anchoring sling and introducer system
US95497993 Jul 201324 Jan 2017Boston Scientific Scimed, Inc.Surgical kit for securing an implantable sling in a pubic region
US955516818 Apr 201631 Jan 2017Coloplast A/SSystem for delivery of medication in treatment of disorders of the pelvis
US956105325 Apr 20077 Feb 2017Medtronic, Inc.Implant tool to facilitate medical device implantation
US957264821 Dec 201121 Feb 2017Justin M. CrankImplantable slings and anchor systems
US95857396 Jun 20147 Mar 2017Ams Research CorporationSurgical articles and methods for treating pelvic conditions
US959204630 May 201414 Mar 2017Ethicon, Inc.Modular tissue securement systems
US962284823 Feb 201218 Apr 2017Boston Scientific Scimed, Inc.Urethral stent system and method
US96362013 May 20122 May 2017Boston Scientific Scimed, Inc.Delivery members for delivering an implant into a body of a patient
US965570831 Dec 201523 May 2017Boston Scientific Scimed, Inc.Systems and methods employing a push tube for delivering a urethral sling
US967543631 Aug 201513 Jun 2017Boston Scientific Scimed, Inc.Pelvic floor repair system
US973738823 Jul 201522 Aug 2017Ams Research CorporationImplants, tools, and methods for treatment of pelvic conditions
US975059028 Mar 20125 Sep 2017Andrew P. VanDeWegheImplants, tools, and methods for treatment of pelvic conditions
US978224530 Mar 201210 Oct 2017James R. MujwidImplants, tools, and methods for treatment of pelvic conditions
US9808241 *3 Apr 20137 Nov 2017Medos International SarlSuturing apparatus and method
US20030220538 *28 Feb 200327 Nov 2003Bernard JacquetinMethod and apparatus for treating pelvic organ prolapses in female patients
US20050021086 *27 May 200427 Jan 2005Jean De LevalSurgical procedure for the treatment of female urinary incontinence: tension-free inside-out transobturator urethral suspension
US20050027220 *31 Jul 20033 Feb 2005James WagnerBioabsorbable casing for surgical sling assembly
US20050072751 *4 Oct 20047 Apr 2005Price Michael L.Tamper evident closure with locking band and container therefor
US20050075660 *4 Oct 20047 Apr 2005Chu Michael S. H.Systems and methods for delivering a medical implant to an anatomical location in a patient
US20050256366 *5 May 200517 Nov 2005Chu Michael S HSystems and methods employing a push tube for delivering a urethral sling
US20050267325 *26 Apr 20051 Dec 2005Ams Research CorporationSurgical implants and related methods
US20050267522 *25 Oct 20041 Dec 2005Cardiva Medical, Inc.Self-tensioning vascular occlusion device and method for its use
US20050277807 *8 Jun 200515 Dec 2005Maclean BrianSystems and methods for sling delivery and placement
US20050288708 *6 Oct 200429 Dec 2005Kammerer Gene WSoft tissue fastener having integral biasing section
US20060015069 *8 Jun 200519 Jan 2006C.R. Bard, Inc.Transobturator introducer system for sling suspension system
US20060058575 *15 Sep 200416 Mar 2006Vincenza ZaddemSystem and method for surgical implant placement
US20060063969 *7 Jan 200523 Mar 2006Edgard CornierDevice for fitting a uterine suspension prosthesis for the treatment of uterine prolapse
US20060089524 *25 Oct 200427 Apr 2006Chu Michael S HSystems and methods for sling delivery and placement
US20060173237 *17 Mar 20063 Aug 2006Bernard JacquetinMethod and apparatus for treating pelvic organ prolapses in female patients
US20060196788 *2 Feb 20057 Sep 2006Peter KomarnyckyPackaging assembly for surgical mesh implants
US20060229596 *6 Apr 200612 Oct 2006Boston Scientific Scimed, Inc.Systems, devices, and methods for treating pelvic floor disorders
US20060258898 *28 Apr 200616 Nov 2006Montpetit Karen PPelvic floor health articles and procedures
US20060293690 *18 Aug 200528 Dec 2006Custom Spine, Inc.Rod reducer
US20070173900 *24 Jan 200626 Jul 2007Medtronic, Inc.Transobturator lead implantation for pelvic floor stimulation
US20080269716 *25 Apr 200730 Oct 2008Medtronic, Inc.Medical device implantation
US20080269740 *25 Apr 200730 Oct 2008Medtronic, Inc.Cannula configured to deliver test stimulation
US20080269763 *25 Apr 200730 Oct 2008Medtronic, Inc.Implant tool to facilitate medical device implantation
US20080287731 *15 May 200820 Nov 2008Generic Medical Devices, Inc.Needle instruments and implantable sling assembly; kits comprising these components; and methods for use
US20080287732 *15 May 200820 Nov 2008Generic Medical Devices, Inc.Needle instruments and implantable sling assembly; kits comprising these components; and methods for use
US20080287971 *15 May 200820 Nov 2008Generic Medical DevicesNeedle instruments and implantable sling assembly; kits comprising these components; and methods for use
US20090259094 *28 May 200915 Oct 2009Ams Research CorporationMethod and Apparatus for Prolapse Repair
US20090275978 *6 Jul 20095 Nov 2009Cardiva Medical, Inc.Self-tensioning vascular occlusion device and method for its use
US20100106246 *24 Oct 200829 Apr 2010Ethicon, Inc.Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea
US20100108077 *30 Oct 20086 May 2010Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US20100132719 *1 Dec 20083 Jun 2010Ethicon, Inc.Implant systems and methods for treating obstructive sleep apnea
US20100222641 *10 May 20102 Sep 2010Boston Scientific Scimed, Inc.Systems and methods for delivering a medical implant to an anatomical location in a patient
US20100256442 *16 Feb 20077 Oct 2010Ogdahl Jason WSurgical Articles and Methods for Treating Pelvic Conditions
US20100261955 *25 Jul 200814 Oct 2010O'hern Jeffrey MichaelPelvic floor treatments and related tools and implants
US20100262158 *21 Jun 201014 Oct 2010Medtronic, Inc.Transobturator lead implantation for pelvic floor stimulation
US20100298630 *5 Dec 200825 Nov 2010Shawn Michael WignallPelvic floor treatments and related tools and implants
US20110124954 *22 Jun 200726 May 2011Ams Research CorporationAdjustable tension incontinence sling assemblies
US20110144558 *15 Dec 200916 Jun 2011Ethicon, Inc.Fluid filled implants for treating medical conditions
US20110152914 *23 Dec 201023 Jun 2011Boston Scientific Scimed Inc.Less traumatic method of delivery of mesh-based devices into human body
US20110216765 *11 May 20118 Sep 2011Jeyhan KaraoguzMedia exchange network supporting multiple broadband network and service provider infrastructures
US20130060080 *4 Sep 20127 Mar 2013Ams Research CorporationPelvic Implant Needle System and Method
US20130226231 *3 Apr 201329 Aug 2013Depuy Mitek, Inc.Suturing Apparatus and Method
US20160015386 *28 Sep 201521 Jan 2016Terumo KabushikiPuncture needle assembly
USD7211758 Sep 201113 Jan 2015Ams Research CorporationBackers for surgical indicators
USD7218078 Sep 201127 Jan 2015Ams Research CorporationSurgical indicators
USD7363828 Sep 201111 Aug 2015Ams Research CorporationSurgical indicator with backers
USD7464628 Dec 201429 Dec 2015Ams Research CorporationSurgical indicators
EP1753488A2 *8 Jun 200521 Feb 2007C.R.Bard, Inc.Transobturator introducer system for sling suspension system
EP1753488A4 *8 Jun 200519 Dec 2012Bard Inc C RTransobturator introducer system for sling suspension system
EP1977699A25 May 20058 Oct 2008AMS Research CorporationKit for repairing cystocele
EP3028683A1 *16 Jul 20128 Jun 2016Cook Medical Technologies LLCA kit to be used in the treatment of obstructive sleep apnea
WO2013048901A1 *21 Sep 20124 Apr 2013Ethicon, Inc.Modular tissue securement systems
WO2014178070A1 *16 Apr 20146 Nov 2014Mangesh PatankarSling system with removable string
Classifications
U.S. Classification606/151, 606/139, 606/104
International ClassificationA61B17/32, A61B17/30, A61B19/00, A61F2/48, A61B17/06, A61B17/00, A61B19/02, A61B17/04, A61F2/00
Cooperative ClassificationA61B17/0469, A61B17/06109, A61B2017/320056, A61F2/0045, A61B2017/00946, A61F2250/0084, A61B2017/00805, A61B50/30, A61B17/0482, A61B2017/06076, A61B17/0487, A61B17/06066, A61B2017/06009, A61B2017/0417, A61B17/0401, A61B17/30, A61B90/02, A61F2002/30708, A61B17/3211
European ClassificationA61B17/04A, A61B17/04K, A61F2/00B6B4, A61B17/06N12
Legal Events
DateCodeEventDescription
27 May 2003ASAssignment
Owner name: AMS RESEARCH CORPORATION, MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ANDERSON, KIMBERLY A.;WATSCHKE, BRIAN P.;MELLIER, GEORGES;AND OTHERS;REEL/FRAME:013681/0384;SIGNING DATES FROM 20030410 TO 20030502
27 Jun 2003ASAssignment
Owner name: BANK OF AMERICA, N.A., AS AGENT, NORTH CAROLINA
Free format text: NOTICE OF GRANT OF SECURITY INTEREST;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:014214/0796
Effective date: 20000417
30 Jul 2004ASAssignment
Owner name: AMS RESEARCH CORPORATION, MINNESOTA
Free format text: SECURITY INTEREST RELEASE;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:015627/0073
Effective date: 20040701
19 Jul 2006ASAssignment
Owner name: AMS RESEARCH CORPORATION, MINNESOTA
Free format text: RELEASE OF SECURITY INTEREST (SUPERCEDING RELEASE RECORDED ON JULY 30, 2004 AT REEL 015627 FRAME 0073.);ASSIGNOR:BANK OF AMERICA, N.A., AS AGENT;REEL/FRAME:017957/0639
Effective date: 20060717